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Abstract
MacDonald, Joan K., M.S., September 1988, Exercise 
Physiology
COMPARISON OF PHYSICAL FITNESS BETWEEN TYPE II 
DIABETICS AND THE APPARENTLY HEALTHY POPULATION
Director of Thesis: Lawrence A. Golding, Ph.D.
Physical fitness was measured in a Type II 
diabetic population and compared to apparently healthy 
men and women. Eighty-eight female Type II diabetics, 
aged over 40 years were compared to 2,008 normal 
females of the same age, and 138 male Type II 
diabetics were similarly compared to 2,271 normal 
males. The National YMCA physical fitness test 
battery was used to measure fitness which consisted of 
flexibility, muscular strength and endurance, 
cardiorespiratory fitness, body composition, and 
resting values of heart rate and blood pressure. 
Differences in the mean values of each parameter were 
tested for significance (p<0.05) using the Z "x test. 
Diabetic females were significantly heavier, stronger 
in the upper body and had higher resting heart rates 
and blood pressures. Their recovery heart rates and 
abdominal strength were poorer than normal females. 
Male diabetics also were significantly heavier and had 
higher heart rates and blood pressures than normal 
males. Their recovery heart rates and abdominal 
strength were poorer than normal males. There was no
significant difference between normals and diabetics 
in percent body fat or flexibility. Although 
significant differences were found in V02 max and PWC 
max in both males and females, the results were 
conflicting. This was believed due to measurement 
errors, and consequently, it is too premature to make 
a statement concerning this measurement of 
cardiorespiratory fitness. Since significant 
differences in most fitness variables existed, it must 
be assumed that Type II diabetics do not belong to the 
apparently healthy population fitness wise, therefore, 
norm tables should be developed for Type II diabetics.
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CHAPTER 1
Introduction
Diabetes mellitus, a syndrome of insulin 
deficiency manifested by abnormalities in the 
metabolism of carbohydrates, fats, and proteins, is 
the third leading cause of death and the primary cause 
of blindness in the United States (Mazzaferri, 1986; 
Guthrie and Guthrie, 1982) . There are currently more 
than 10 million diabetics in this country and it is 
predicted that by 1990, 20 million people will have 
the disease (National Commission Reports. 1975). The 
nearly incomprehensible mortality rate of several 
hundred thousand deaths per year associated with 
diabetes and its complications (Guthrie and Guthrie, 
1982; Krolewski and Warram, 1985) and the impact on 
related economic costs, underscore a desperate need to 
either find a cure or learn how to properly control 
the disease.
Although physical exercise is not a panacea, its 
role in preventing certain diseases and as a 
therapeutic agent in others has long been recognized. 
Although still controversial, the value of exercise in 
the treatment of diabetics has been emphasized for 
more than one thousand years (Kemmer and Berger,
1986). However, it has only been within the last
2decade that research in this area has accelerated, 
with the vast majority of it being centered around the 
metabolic adaptations or modifications to exercise 
training. Little research has been completed 
establishing guidelines for exercise in this 
population, and as such, the current ones are often 
inadequate.
Nationally acceptable guidelines are available 
for the apparently healthy individuals who wish to 
begin an exercise program, as extensive baseline data 
have been accumulated for this population (Golding et 
al., 1982; Golding et al., in press). After receiving 
proper medical approval, the apparently healthy 
individuals may complete a battery of standardized 
tests designed to measure their exercise tolerance and 
cardiorespiratroy reserve capacity. The results can 
then be compared to norm tables and an individual's 
fitness level, relative to a specific sex and age 
group, can be determined. Exercise programs can 
subsequently be recommended, giving the appropriate 
kind of exercises at the proper intensity. However, 
it is not known at this time if safe and effective 
exercise guidelines can be established for the 
diabetic based on these nationally established norms 
for the apparently healthy population.
STATEMENT OF THE PROBLEM 
Diabetes is often associated with additional 
medical complications such as atherosclerosis, 
nephrosclerosis, neuropathy and other cardiovascular 
changes (Legg and Harawi, 1985) and as such, the 
physical capacity of the diabetic may be lower than 
that of the normal population. If this is true, 
prescribing exercise programs based on the healthy 
population may not be entirely appropriate. The 
purpose of this study was to determine whether Type II 
diabetics have a fitness level different from that of 
the apparently healthy population. If found to be 
different, norm tables specific to the diabetic 
population should then be developed.
STATEMENT OF NEED AND SIGNIFICANCE 
The value of exercise has long been recognized in 
the treatment and control of the diabetic, especially 
when combined with proper diet and insulin control 
(Ruderman and Schneider, 1986) . Universally 
acceptable exercise programs, however, do not 
currently exist for this population. In order to 
diminish the mortality and morbidity rate associated 
with this disease, there is an obvious need for the 
development of safe, proper and effective exercise
4programs. The first step, however, in designing any 
program should be to determine the fitness level.
LIMITATIONS AND/OR ASSUMPTIONS
In all studies, there are unavoidable limitations 
that may restrict the inferences resulting from the 
collected data. Additionally, certain assumptions 
must be made about the subjects and the procedures 
that may or may not be true. The following are the 
most apparent limitations and assumptions encountered 
in this study.
1. This study was limited to determining the 
fitness level of Type II (NIDDM) diabetics and as 
such, no inferences should be made about the Type I 
(IDDM) diabetics.
2. There were no time restraints imposed on the 
actual testing. The subjects were instructed to eat, 
drink, sleep as usual, and to take their medication as 
prescribed. They were asked, however, to refrain from 
smoking for at least two hours prior to testing.
3. Circadian rhythms and their effect on
performance were not be considered during the study.
4. Since the majority of type II diabetics are
over the age of 40, there will be an insufficient
number of younger subjects to supply data for new norm
tables if developed. This will also limit the 
inferences that can be made to the entire population.
5. It was assumed that the subjects obtained 
were a true representation of the type II diabetic. 
This, however, may not be the case, as all subjects 
were volunteers, and in so being, possibly represent a 
more highly motivated group than the average type II 
diabetic.
DEFINITIONS
1. DIABETES-— defined as a variety of disorders 
characterized by polyuria (excessive urination). It is 
derived from the Greek work meaning "to siphon or to 
pass through".
2. MELLITUS— a general term used to identify a 
group a syndromes stemming from abnormal glucose 
oxidation and utilization. It is derived from the 
Latin word for "honey" and refers to the urine being 
sweetened by sugar.
3. TYPE I DIABETIC— also called 
insulin-dependent diabetes mellitus (IDDM), or 
formerly known as ketosis-prone, juvenile, unstable, 
or brittle diabetes. The insulin-producing cells of 
the pancreas fail to produce enough insulin to 
maintain normal levels of blood sugar. Lifelong
6exogenous insulin injections are, therefore, required 
to maintain normal metabolic function.
4. TYPE II DIABETIC— also called 
non-insulin-dependent diabetes (NIDDM), or formerly 
known as adult-onset, maturity-onset, 
ketosis-resistant, or stable diabetes. Insulin is 
generally produced in sufficient quantities, but 
because of a malfunction that is usually associated 
with obesity, the system cannot effectively utilize 
this insulin to control the blood sugar. The majority 
of type II diabetics can be controlled by diet and/or 
oral medications. Some, however, may temporarily 
require exogenous insulin to achieve control, 
especially while they are obese.
5. GLUCOSE— a simple sugar providing the chief 
source of energy for the body cells. The metabolic 
rate of glucose is controlled by insulin.
6. GLYCOGEN— a polysaccharide considered to be 
the chief carbohydrate storage material in animals.
It is formed and stored in the liver and muscles.
7. GLYCOGENOLYSIS— the conversion of glycogen to 
glucose in the liver.
8. GLUCONEOGENESIS— the synthesis of glucose 
from noncarbohydrate sources such as amino acids and 
glycerol usually stimulated by cortisol and other
glucocorticoids and tetraiodothyronine (T4). This 
synthesis generally occurs in the liver and kidneys.
9. KETOGENESIS— the formation of ketone bodies 
that are the normal metabolic products of lipid and 
pyruvate within the liver. These are normally 
oxidized by the muscles.
10. INSULIN— the major fuel-regulating hormone 
produced in the beta cells of the pancreas that is 
secreted into the blood in direct response to blood 
glucose or amino acid concentrations. It facilitates 
the uptake, utilization, and storage of glucose, fat, 
and amino acids; it increases the synthesis of 
glycogen and fatty acids in the liver, of glycerol and 
fatty acids in adipose tissue, and of protein and 
glycogen in muscle tissue; it inhibits glycogenolysis, 
gluconeogenesis, and ketogenesis in the liver, 
lipolysis in adipose tissue; and decreases protein 
catabolism and amino acid output in muscle tissue 
(Sherwin et al., 1978).
8CHAPTER 2 
Review of the Related Literature
Historical Aspects of Diabetes Mellitus
The earliest knowledge of diabetes can be traced
to 1500 B. C. when an illness characterized by the
passage of much urine was described by the German
archaeologist, Papyrus Ebers (Cahill, 1985). The
disease was named diabetes, meaning siphon, in the 2nd
Century by Aretaeus who also provided the first
clinical description as cited below:
Diabetes is a wonderful affection...being a 
melting down of the flesh and limbs into 
urine...the patients never stop making water, 
but the flow is incessant as if from the 
opening of aqueducts...the patient is short 
lived...for the melting is rapid, the death 
speedy.
(Aretaeus, 2nd century)
Many centuries passed with little progress made 
in the understanding of the disorder. Finally in 
1869, the German physician Paul Langerhans discovered 
"islands" within the pancreas, although he was unsure 
of their physiological function. This, however, 
eventually lead to the next major discoveries by the 
German scientists von Mering and Minkowski and the 
American scientist Opie early in the 19th Century.
The results of their works implicated the beta cells 
in the pancreas as the origin of the disease. The 
greatest scientific breakthrough occurred in 1921 when
the Canadian physician Fredrick Banting and his 
graduate assistant, Charles Best were able to lower 
the blood glucose levels in diabetic dogs by 
administering prepared extract of pancreas. This 
resulted in a Nobel Prize and to a reversal in the 
morbid outcome of the disease by treating diabetics 
with exogenous insulin (Poulsen, 1967).
Classification of Diabetes Mellitus 
Cahill (1985) stated that diabetes mellitus "is a 
grouping of anatomic and chemical problems resulting 
from a number of factors in which an absolute or 
relative deficiency of insulin or its function usually 
is present" (page 3). The disease can be classified 
through an entire spectrum of clinical symptoms 
ranging from a total lack of insulin to a slightly 
diminished functional ability of the insulin. It has, 
however, historically been classified into the two 
main groups of "juvenile-onset" and "maturity-onset" 
diabetes.
In the juvenile-onset diabetic, insulin is almost 
always totally lacking and those primarily affected 
are children or adolescents. Without insulin, death 
is probable within a few days from the ketoacidosis 
resulting from the impaired carbohydrate metabolism. 
Consequently, this is also referred to as
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"ketosis-prone" or "insulin-dependent" diabetes 
mellitus (IDDM). It is currently more commonly 
referred to as Type I diabetes (Mazzaferri, 1986).
The maturity-onset, or Type II, diabetic, 
primarily has a deficiency in the functional ability 
of the insulin, not necessarily a reduction in 
quantity. In many cases there is an increase in the 
insulin level which is believed to be due to the 
obesity and/or lack of exercise that often accompanies 
this particular form of diabetes (Cahill, 1985). 
Ketoacidosis and death are unlikely to occur even in 
the absence of exogenous insulin. Consequently, this 
is called "non-insulin dependent diabetes mellitus" 
(NIDDM) although insulin may be required for control 
and regulation. Also as implied by the name, 
maturity-onset diabetes is usually manifested during 
the later years of life (50s or 60s) .
Interrelationships of Fuels and Hormones 
in the Apparently Healthy Population
In order to understand the defective metabolism 
resulting from diabetes, the normal relationship 
between insulin and other hormones to fuel metabolism 
is reviewed from several sources.
Insulin-Glucose Mechanism
Glucose. Since the nervous system is virtually 
incapable of oxidizing any nutrients other than
glucose for energy, a constant supply of this sugar is 
necessary for continued survival. Fortunately, the 
composition of glucose can be altered following 
absorption so that the glucose not immediately used 
for energy may either be stored as glycogen in the 
liver and skeletal muscle or transformed into fat and 
stored in the liver and adipose tissue for future use 
in the postabsorptive state (Aoki, 1985). Through the 
actions of various hormonal and neuronal factors, the 
levels of this indispensible fuel are precisely 
regulated and controlled.
The molecular weight of glucose, although 
relatively small at 180, is actually too large to 
allow this sugar to cross the cellular membrane and 
enter the cytoplasm through the rapid process of 
simple diffusion. It, nevertheless, can be 
transported across the membrane through the mechanism 
of facilitated diffusion. This process can be 
increased by more than a factor of 10 when stimulated 
by insulin (Guyton, 1986). In fact, .without insulin, 
only trace amounts of glucose could be transported 
into most cells of the body and death would be 
inevitable. The brain, being the major exception, 
will take up glucose in the absence of insulin.
Insulin. Insulin is secreted by the beta cells 
of the islets of Langerhans within the pancreas
12
primarily in response to an elevation in blood 
glucose. Specific amino acids (arginine and leucine) 
and beta adrenergic activity may also stimulate 
insulin secretion (Mazzaferri, 1986). The majority of 
this protein binds to specific receptors in the cell 
membrane of the target cells that subsequently become 
activated to initiate the insulin effects. These 
receptors are believed to be more than simple carriers 
of insulin from the extracellular to the intracellular 
space. Several investigators (Craig et al., 1981; 
LeBlanc et al., 1979) have shown that the insulin 
effect can be significantly modified by changing the 
numbers of receptors per cell and/or by altering the 
affinity of the receptors for insulin. These 
structures may, therefore, be the first site at which 
insulin exerts its effects.
The most important effect of insulin is to 
increase the uptake, storage, and utilization of 
glucose in most of the cells in the body, 
particularily in liver, muscle and adipose tissues.
The insulin not used is expeditiously removed from the 
circulatory system and decomposed in the liver and to 
a lesser degree in the kidneys (Guyton, 1986).
The Liver and Insulin
The major effects of insulin on the liver are to 
stimulate glycogen synthesis and to inhibit glucose
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output. This is accomplished through the following 
steps which are performed almost simultaneously upon 
the secretion of insulin: the enzyme, phosphorylase,
that causes glycogen to be split into glucose is 
inhibited thereby preventing the breakdown of glycogen 
already stored in the liver; the activity of the 
enzyme, glucokinase, which causes the initial 
phosphorlation of glucose within the liver cells is 
increased causing the enhancement of glucose uptake; 
and the activity of the enzymes responsible for 
promoting glycogen synthesis, phosphofructokinase and 
glycogen synthetase, are increased thus increasing the 
glycogen concentration (Guyton, 1986).
Insulin also acts on the liver cells to help 
convert any excess glucose into fatty acids for 
storage as fat in adipose tissue. It additionally 
functions to inhibit gluconeogensis (hepatic synthesis 
of glucose from amino acids, glycerol, pyruvate and/or 
lactate) by decreasing the amount and the activity of 
the enzymes responsible for the creation of glucose 
from these noncarbohydrate sources (Guyton, 1986).
Once the blood glucose falls to low levels, as 
occurs within a few hours following a meal, all the 
above mentioned effects of insulin are reversed: 
insulin secretion is decreased; uptake of glucose from 
the blood is no longer enhanced thereby preventing
glycogen synthesis; the enzyme, phosphorylase, is 
activated causing glycogen to split into glucose 
phosphate; and the phosphate radical is removed from 
the glucose by the enzyme glucose phosphatase, 
allowing free glucose to diffuse back into the blood. 
The process of glycogenolysis, or the converting of 
glycogen into glucose is thus enhanced when blood 
glucose levels, and corresponding insulin levels, are 
low.
Muscle Tissue and Insulin
When insulin secretion is minimal, as in the 
postabsorptive state, the resting muscle does not 
generally use glucose as an energy source. The 
cellular membrane, in this situation, is nearly 
impermeable to glucose. Fatty acids, instead, provide 
the energy. This is evidenced from the fact that the 
resting respiratory quotient (RQ) for muscle is 
approximately 0.7, indicating that fat is almost the 
sole substrate used for oxidative metabolism in the 
postabsorptive state (Bjorkman, 1986). Resting muscle, 
however, will utilize glucose before fats during the 
first few hours following a meal as the insulin 
concentration is high at this time (Guyton, 1986).
The majority of the glucose taken into the 
resting muscle following a meal is stored in the form 
of muscle glycogen and used most frequently to provide
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immediate energy during short spurts of anerobic 
activity through the mechanism of glycolysis 
(anaerobic conversion of glucose to lactate or pyruvic 
acid primarily to provide energy in the form of ATP to 
working muscles). Those carbohydrates stored as 
muscle glycogen are not. readily available to the 
plasma glucose pool as the enzyme, glucose 
phosphatase, as mentioned above, is not present in 
muscle tissue as it is in liver tissue (Wahren, 1979). 
Fat Metabolism and Insulin
The ultimate effect of insulin on fat metabolism 
is to enable fat to be properly stored. This is 
essentially accomplished through the promotion of 
fatty acid synthesis in the liver and to a lesser 
degree in the adipocytes themselves.
Glycogen synthesis within the liver becomes 
inhibited once the glycogen concentration reaches 
approximately 5 to 6 percent. Consequently any 
additional glucose in the liver will be transformed 
into fatty acids as acetyl-CoA, the substrate 
responsible for the synthesis of fatty acids, is 
produced from the glucose entering the glycolytic 
pathway (Guyton, 1986). Some of these fatty acids are 
retained in the liver to synthesize triglycerides, the 
majority of which are subsequently released into the 
blood in the lipoproteins. Once the triglycerides
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reach the adipocytes, if insulin is present, they will 
be converted back into fatty acids by the action of 
the enzyme, lipoprotein lipase, so that they may be 
absorbed into the fat cell. Once inside the cell, 
they will be reconverted back into triglycerides for 
storage. Those fatty acids produced in the liver and 
not synthesized into triglycerides are simply 
transported to the adipose cells for storage.
Insulin also stimulates the synthesis of fatty 
acids within the adipose cells in a similar manner as 
observed in the liver cells. However, since the 
adipocytes only receive about one-tenth as much 
glucose as do the liver cells, the synthesis of fatty 
acids is drastically reduced here (Guyton, 1986). 
However, not all of the glucose entering the fat cell 
in response to insulin is used to synthesize fatty 
acids. Some of it is used to produce 
alpha-glycerophosphate from which the essential 
substance, glycerol, is formed. Glycerol is what 
binds with fatty acids in the adipose cells to produce 
the storage form of fats, the triglycerides.
In addition to the important function of 
synthesizing fatty acids, insulin inhibits the enzyme 
responsible for the hydrolysis of the triglycerides 
and the subsequent release of fatty acids into the
17
blood. This helps to maintain acceptable circulating 
blood levels of free fatty acids and glycerol.
Protein Metabolism and Insulin
Although the mechanisms are not completely 
understood, insulin serves two vital functions in the 
metabolism of proteins, namely the promotion of 
protein formation and the prevention of protein 
degradation. These are, in part, accomplished by the 
following actions of increased insulin: the uptake of
certain amino acids into cells is increased; the 
ribosomes are stimulated to produce new proteins by 
increasing the translation of messenger RNA 
(ribonucleic acid); the catabolism of proteins is 
inhibited resulting in a decreased release of amino 
acids from the cells; and the rate of gluconeogenesis 
is decreased by decreasing the activity of certain 
enzymes (Guyton, 1986).
The Control of Insulin Secretion
Glucose. According to Zawalich (1985), the most 
important physiologic regulator of insulin secretion 
is glucose. This insulin-glucose mechanism provides a 
positive feedback control over the plasma levels of 
both insulin and glucose. A rise in blood glucose 
stimulates insulin secretion which in turn enhances 
the entry of glucose into most cells. This decreases
18
the blood glucose level which subsequently causes the 
beta cells to reduce their secretion of insulin.
Amino Acids. The amino acids, particularily 
arginine and leucine (Mazzaferri, 1986) have a similar 
effect on insulin secretion as does glucose. However, 
it has been shown that when amino acids are present 
without an increase in the glucose level, insulin 
secretion will be minimal. If, however, the amino 
acids are administered at the same time the blood 
glucose level is elevated, the insulin secretion may 
even double that normally seen with the glucose 
elevation alone. This helps to promote the active 
transport of amino acids into the cells and eventual 
new protein formation as discussed above.
Other hormones. Almost immediately after a meal 
is eaten, certain hormones are released from the 
gastrointestinal tract to effect a rise in the insulin 
level. These include gastrin, secretin, 
cholecystokinin, and gastric inhibitory peptide.
They, in essence, act as early messengers, causing an 
initial rise in insulin in order to be ready for the 
increased glucose and amino acids to be forthcoming 
after absorption.
The insulin stimulating hormones such as 
glucagon, growth hormone, cortisol, epinephrine, and
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others will be discussed in greater detail during the 
section on fuel metabolism and exercise.
Interrelationships of Fuels and Hormones 
in the Diabetic Individual
It should be evident from the previous discussion
that the effects of insulin are far reaching, and that
a deficiency of this hormone will be manifested by an
impairment of carbohydrate, fat and protein
metabolism. The spectrum of insulin's deficiencies,
again, range anywhere from an absolute lack to a
slight reduction in its functional ability, causing a
wide range of complications from death to feeling
tired.
Type I Diabetes
The demise of the beta cells have been implicated 
as being the sole cause for either a reduction in or a 
complete absence of insulin secretion leading to Type 
I diabetes. The actual cause of this destruction 
currently remains unknown. It has been hypothesized, 
however, that the damage may result from any one or 
from a combination of the following factors: genetic
inheritance of a cell-mediated autoimmunity producing 
blood antibodies against pancreatic tissue; viral 
infection possibly producing lesions in the islet 
cells; and/or a simple deterioration of the cells due 
to age and/or obesity (Kahn, 1985).
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Type II Diabetes
The reduction in the functional ability of 
insulin rather than its absence characterizes this 
type of diabetic. Currently, the most commonly 
accepted belief is that the reduced biologic effect is 
due to a reduction in the number of the target-tissue 
insulin receptors or to a reduction in the insulin 
sensitivity of the receptors (Guyton, 1986). The main 
underlying cause of both of these possible 
explanations is obesity, as approximately 85 percent 
of the adults with the disease are obese (Guthrie and 
Guthrie, 1982). Obesity, as explained by Guyton 
(1986), may cause the beta cells themselves to become 
less responsive to insulin and it may also decease the 
number and the sensitivity of the target receptors.
It has also been suggested that in some Type II 
diabetics, the deficiency in insulin action may be the 
result of the beta cells secreting a less active 
insulin molecule or that the normal insulin molecule 
is somehow rendered inactive during its transportation 
to the target cells (Mazzaferri, 1986).
Additionally, there seems to be a strong 
hereditary trait for Type II diabetes. This was 
supported by a study in which normoglycemic 
individuals with familial aggregation of Type II 
diabetes were compared to normal control subjects
(Berntorp and Lindgarde, 1984). All subjects were 
presented with oral glucose tolerance tests and 
simultaneously measured for insulin, C-peptide levels 
and submaximal exercise performance ability. The 
results showed that those with familial history had 
significantly lower insulin levels after 40 minutes of 
exercise and significantly lower maximal oxygen uptake 
values. These data suggest that the hereditary trait 
was manifested as a decreased sensitivity of the beta 
cells to glucose stimulation and as a lower fitness 
level.
Regardless of the type of diabetes, an absolute 
or relative lack of insulin will produce the following 
effects in varying degrees: (1) abnormal carbohydrate
metabolism producing an abnormal rise in blood glucose 
(from 300— 1200 mg/dl); (2) abnormal fat metabolism 
causing increased mobilization of fat and consequent 
increased deposit of lipids in the circulatory system; 
and (3) abnormal protein metabolism resulting in 
protein depletion of the tissues (Guyton, 1986). The 
diabetic essentially presents as a paradox in that 
their cells are starving even in the presence of 
abnormally high blood glucose levels.
Abnormal Carbohydrate Metabolism of Diabetes
Just as insulin increases the uptake, storage and 
utilization of glucose in nearly all the cells in the
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body, a lack of this protein will produce the opposite 
effect. Glucose entry into most of the cells is 
diminished causing an elevation in the blood glucose 
concentration. Glycogenolysis is enhanced as the 
cells signal for food thus releasing more glucose into 
the blood. And without.excess glucose in the cells, 
muscle glycogen will not be available to furnish 
immediate energy through glycolysis (Guthrie and 
Guthrie, 1982).
If the fasting glucose levels rise above 180 
mg/dl of blood, the renal threshold is exceeded and 
glucose "spills" (Cahill, 1985) into the urine 
(glucosuria). This fasting hyperglycemia is 
indicative of an insulin deficiency; the higher the 
blood glucose concentration, the more severe the 
deficiency (Cahill, 1985). This in turn leads to an 
increase in thirst (polydipsia) and hunger 
(polyphagia), and to excessive urine output (polyuria) 
(Guyton, 1986).
Abnormal Fat Metabolism of Diabetes
In the absence of insulin, the fat cells attempt 
to provide the main energy substrate for almost all 
the cells except those in the brain. The fat cells 
become activated to hydrolyze the stored triglycerides 
and thus release large amounts of fatty acids and 
glycerol. Many of the free fatty acids are used for
23
energy but the majority of them diffuse into the liver 
cells where they are reconverted and stored as 
triglycerides.
Phospholipids and cholesterol are produced in the 
liver in response to the excessive fatty acids. They 
then may join some of the triglycerides, leave the 
liver and enter the blood stream in the lipoproteins. 
This elevation of the blood lipid concentration is 
responsible for the atherosclerosis present in those 
having a serious diabetic disorder (Guyton, 1986).
Also, in the absence of insulin, the increased 
fatty acids in the liver produce large amounts of 
acetyl-CoA which can be used, to some extent, to 
provide energy. The unused portion is condensed to 
form acetoacetic acid and released into the blood. 
Under normal circumstances, this is reconverted in the 
periphery to form acetyl-CoA for use as energy. 
However, this process is diminished when insulin is 
lacking, leading to a large accumulation of 
acetoacetic acid. Two additional acids are also 
formed in the liver from acetoacetic acid. These are 
beta-hydroxybutyric acid and acetone. Collectively, 
these three acids are referred to as the ketone 
bodies. When present in large quantities a state of 
"ketosis" results. These acids, especially 
acetoacetic acid and beta-hydroxybutyric acid,
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generate large amounts of hydrogen ions leading to 
acidosis, coma and death if left untreated (Vignati, 
Asmal et al., 1985).
Abnormal Protein Metabolism of Diabetes
Without insulin, the following events occur: the
active transport of many of the amino acids into the 
cells is inhibited; new protein formation is 
diminished; the amino acids are released from the 
cells at an increased rate, especially from the muscle 
cells; and gluconeogenesis is enhanced as the plasma 
amino acids are the primary substrate used for the 
production of new glucose, and these have drastically 
increased (Guyton, 1986). A lack of insulin, 
therefore, promotes the degradation of proteins and 
practically causes protein synthesis to cease.
Protein degradation ultimately leads to a wasting away 
of tissue, or to the "melting down of the flesh and 
limbs into urine" (Cahill, 1985).
Exercise and Diabetes Mellitus
Fuel Regulation during Exercise in General
At the onset of exercise, metabolic fuels must be 
rapidly mobilized and redistributed throughout the 
body in order to provide energy for the working 
muscles. Since glycogen is stored in the muscles and 
does not have to be mobilized and recirculated before
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use, it is the initial source of energy during 
exercise. It, however, is in limited quantity and 
other fuel substrates must be made available for 
continued work. The primary circulating fuels used by 
contracting muscles are glucose and free fatty acids 
with amino acids and ketone bodies being used to 
lesser degree (Richter and Galbo, 1986).
Free fatty acids provide the majority of energy 
to the muscles in the resting state. However, with 
the initiation of exercise, glycogen is utilized 
first. Then, depending on the intensity and duration 
of exercise, glycogen, plasma glucose and free fatty 
acids are used in varying combinations. Finally, if 
exercise is prolonged, the free fatty acids become the 
major energy-providing fuel (Zinman and Vranic, 1985). 
Plasma glucose concentration is, however, the limiting 
factor during prolonged exercise, as the body cannot 
exist soley on free fatty acids (Guyton, 1986). If 
the hepatic production of glucose through 
glycogenolysis and/or gluconeogenesis is so low that a 
hypoglycemic condition exists and if the muscle 
glycogen stores become depleted, working capacity 
decreases (Bergstrom and Hultman, 1967).
The normal physiologic responses to exercise of 
varying intensity and duration depend upon proper 
metabolic, hormonal, and neuronal regulation.
Diabetes represents a multifaceted disease in which 
regulatory control mechanisms have been altered, and 
as such, the physiologic responses to exercise may not 
be the same in these individuals as in healthy 
subjects. Although there are differences between the 
two main diabetic types, both have abnormal glucose 
homeostasis mechanisms potentially causing abnormal 
responses to exercise. The responses are primarily 
dependent upon the diabetic's current state of 
metabolic control and are discussed below.
Metabolic Responses of the Diabetic to Exercise
Muscle Glycogen. Three studies cited by Bjorkman 
(1986) have revealed that exercising diabetics utilize 
glycogen at the same rate as the apparently healthy 
population. They may also have the same muscle 
glycogen content, depending upon their state of 
metabolic control, a state directly related to the 
level of insulin (Wahren, 1979). Those who are in a 
state of chronic insulin deficiency, however, are 
likely to show a decreased glycogen content with 
abnormal metabolism and an impaired aerobic capacity. 
It has, in fact, been demonstrated that after 40 
minutes of exercise, the metabolic profile of 
moderately insulin deficient diabetics was similar to 
that of non-diabetics who had exercised up to 4 hours 
(Wahren, Sato et al., 1984), indicating considerably
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accelerated responses in this diabetic state. Insulin 
therapy has been shown to return decreased glycogen 
levels and the aerobic exercise capacity to that of 
healthy individuals (Yki-Jarvinen and Koivisto, 1983).
The main difference between muscle glycogen in 
the diabetic and in the normal individual is that the 
contribution of glycogen to the total exercising 
energy expenditure is less in the diabetic. This was 
indirectly evidenced from a study on insulin dependent 
diabetics whose muscle oxygen and substrate uptakes 
were measured during exercise (Wahren, Hagenfeldt et 
al., 1975). The measurement of arteriovenous glucose 
concentration differences across the leg in 
combination with the local RQ provided an indirect 
estimation of muscle glycogen utilization to total 
muscle energy turnover (Bjorkman, 1986). This study 
showed similar estimated glucose contributions to 
total oxidative metabolism (28% versus 25% in 
controls). However, the contribution from free fatty 
acids (FFA) was measured to be 60% higher in the 
diabetic group. Supporting this claim was the 
observation of a lower RQ in the diabetics. Greater 
plasma substrate levels noted in the diabetics (70% 
versus 52%) also support the claim of decreased muscle 
glycogen availability in diabetic subjects (Wahren, 
Hagenfeldt et al., 1975).
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Hepatic Glucose Production. In normal subjects, 
total glucose utilization has been shown to increase 
up to threefold during exercise whereas the blood 
glucose concentration remains virtually the same in 
normal subjects (Wasserman and Vranic, 1986). This is 
because the liver has the ability to synthesize 
glucose from stored glycogen and other fuel 
substrates, providing a source of glucose 
replenishment at almost the same rate as muscle 
glucose utilization.
In normal subjects, the primary source of glucose 
replacement during exercise is hepatic glycogenolysis. 
However, when the glycogen stores become depleted as 
occurs during prolonged exercise, hepatic 
gluconeogenesis is stimulated to increase its role in 
glucose replacement, but it fails to completely 
compenstate for the decreased glycogen breakdown. The 
diminished splanchnic production of glucose then leads 
to lower plasma glucose concentrations and 
insufficient peripheral glucose uptake (Bjorkman,
1986).
Wahren, Hagenfeldt and Felig (1975) have observed 
that the hepatic glucose production in the resting 
state was similar in both insulin deprived diabetics 
and healthy subjects. A considerable increase in the 
contribution of gluconeogenesis to glucose production
was, however, demonstrated in exercising diabetics 
(from 25% in normal subjects to 40% in diabetic 
subjects). This was evidenced from a two-to-fivefold 
increase in gluconeogenic precursors (lactate, amino 
acids, and pyruvate) along with an increased uptake of 
oxygen and FFA during submaximal exercise in 
diabetics. This finding also helps to support the 
theory that the insulin deficient diabetic may show an 
accelerated response to exercise, possibly lowering 
aerobic endurance.
Glucose utilization. One study (Wahren, Felig, 
Ahlborg, and Jorfeldt, 1971) reported a 7 to 10-fold 
increase in leg muscle glucose uptake during mild to 
moderate bicycle riding (65 and 135 watts) and a 
20-ifold rise during strenuous work intensities (200 
watts) in normal subjects. This was evidenced from a 
gradual widening in the femoral arteriovenous glucose 
concentration curve with exercise. Additionally, two 
of these same investigators, Jorfeldt and Wahren, 
demonstrated a similar rise in glucose uptake in the 
small muscles of the forearms during exercise (Wahren, 
1979). The conclusion was that with brief periods of 
work (from 120 to 180 minutes depending upon whether 
the work is low intensity or strenuous, respectively) 
the contribution of glucose to the total oxidative 
metabolism gradually increased, suggesting a greater
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importance of this substrate with duration of 
exercise. The muscle glucose, however, did fall in 
conjunction with the plasma glucose level with 
prolonged exercise (after approximately 2— 3 hours) 
(Wahren, Felig, Ahlborg, and Jorfeldt, 1971).
Wahren, Hagenfeldt and Felig (1975) also 
demonstrated that the total glucose uptake by leg 
muscle during exercise in hyperglycemic, 
insulin-deprived diabetics was at least as great as in 
healthy controls. This could, however, be due to the 
fact that the initial blood glucose concentration was 
considerably higher in the diabetics thereby 
accounting for the relatively normal glucose uptake in 
the leg tissues. Lactate levels were significantly 
higher in these diabetics, suggesting incomplete 
oxidation of glucose through the glycolytic pathway. 
The amount of blood glucose contributing to total 
oxidative metabolism by the leg muscles was not found 
to differ measurably between the controls, mildly 
ketotic or nonketotic diabetic subjects. Oxygen 
uptake, however, was significantly higher in the 
ketotic group, again suggesting an increased use of 
additional energy substrates while in this diabetic 
state (Wahren, Hagenfeldt and Felig, 1975) .
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Hormonal Control of Responses to Exercise
Apparently Healthy Subjects. To provide for the 
increased need of fuel during exercise, certain 
hormonal responses have been characterized. The 
plasma insulin concentration decreases almost 
instantaneously with exercise through a suspected 
alpha-adrenergic stimulation of the beta cells and an 
indirect local release of catecholamines in the liver 
(sympathetic nervous system stimulation) 
that causes an instantaneous release of hepatic 
glucose (Galbo, 1986; Kemmer and Berger, 1986). This 
hypoinsulinemia is believed to play an important 
physiologic role in directly increasing hepatic 
glucose output and in facilitating the mobilization of 
FFA from adipose tissue. It may also inhibit the 
glucose uptake by non-exercising tissues (Richter and 
Galbo, 1986). The decrease in insulin apparently has 
little effect on glucose uptake by working muscles. 
Richter and Galbo (1986) refer to a study by Ploug et 
al. in which it was demonstrated that muscle 
contractions and insulin have additive effects on 
glucose transport and, consequently, only minute 
concentrations of insulin are needed to increase 
glucose uptake.
The question as to how the counter-regulatory 
hormones (catecholamines, glucagon, growth hormone and
cortisol) respond to exercise and the hypoinsulinemia 
remains somewhat unresolved. It is currently believed 
that the plasma glucagon levels do not change but that 
the circulating levels of catecholamines and growth 
hormones do increase with exercise (Bjorkman, 1986; 
Richter and Galbo, 1986). Conflicting data have shown 
that an exercise-induced rise in glucagon levels was 
immediately observed in sheep, rats, and dogs, whereas 
in humans, these levels did not increase until late in 
prolonged exercise when plasma glucose concentrations 
decreased (Richter and Galbo, 1986). It has been 
concluded that these differences are species related 
and that glucagon does not play the same important 
role in increasing hepatic glucose production in 
humans as it does in other species.
The circulating levels of catecholamines, 
norepinephrine and epinephrine, have been seen to vary 
exponentially with intensity of exercise, with 
norepinephrine levels significantly increasing at 
lower workloads than those required to cause a 
significant rise in epinephrine (Galbo, 1980).
Richter and Galbo (1986) mention a study by 
Christensen and Galbo in which the increase in 
norepinephrine was correlated to the proportional 
increase in pulmonary arterial oxygen saturation 
commonly observed with increasing workloads. The
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secretion of epinephrine was determined to be 
dependent upon the levels of norepinephrine as well as 
on the plasma glucose concentration. Specifically, if 
the glucose level was kept constant through continuous 
infusion, the epinephrine levels decreased. Other 
hormones, such as cortisol, growth hormone and 
adrenocorticotropic hormone (ACTH), have all been 
observed to increase with exercise. It is, however, 
currently believed that they do not play a major role 
in maintaining hepatic glucose production except 
during prolonged exercise (Kemmer and Berger, 1986).
Diabetic Individuals. In the type I diabetic, 
the plasma insulin levels are dependent upon the time 
and site of subcutaneous administration and the rate 
of absorption (Zinman, 1984) . The levels can 
fluctuate from excessive to deficient. If the 
pre-existing insulin levels are high, less hepatic 
glucose will be produced and greater glucose clearance 
will occur leading to a lower plasma glucose 
concentration or to a hypoglycemic state. Conversely, 
in the insulin- deficient state, the plasma glucose 
levels will be elevated leading to a hyperglycemic 
and/or ketotic state. This occurs because the liver, 
due to an exaggerated exercise-induced increase in the 
counter-regulatory hormones, increases glucose 
production whereas the muscle tissue shows a
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diminished uptake of glucose (Zinman and Vranic,
1985).
The majority of type II diabetics experience 
hyperglycemia due to an insulin resistance. This 
occurs even in the presence of elevated insulin levels 
that are present in most diabetics (due to obesity). 
The glucose level, however, is still greater than the 
insulin level thereby creating a hyperglycemic 
environment (Ruderman and Schneider, 1986). In a 
study by Galbo (1986), obese diabetics who 
participated in bicycle exercises showed a fall in 
plasma glucose while the insulin level remained the 
same. Obese control subjects, on the other hand, 
remained euglycemic and had a normal decrease in 
insulin concentration (Galbo, 1986).
Bjorkman (1986) referred to a study by Simonson 
et al. in which beta-adrenergic blockade in 
insulin-dependent diabetics inhibited the 
exercise-induced rise in glucose production, 
suggesting that beta-adrenergic stimulation is 
critical during exercise in these subjects. Galbo 
(1986) concluded that the catecholamine response to 
exercise is enhanced in insulin-deficient states such 
as in poorly controlled diabeates, and that this 
response will be depressed if the diabetic has 
autonomic neuropathy. He also found glucagon levels
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to be higher in the insulin-deficient state compared 
to normal subjects.
Fitness Level and the Diabetic
Very few studies comparing the physical fitness 
level of diabetics to the normal population have been 
cited in the literature, and those that have been 
identified have compared only the Type I diabetics 
against the normal population. From those, it was 
concluded that this diabetic population, for not fully 
understood reasons, show a reduced ability to perform 
physical activities (Coram and Mangum, 1986).
The major reason for this decreased ability is 
suspected to be the cardiovascular changes that often 
accompany diabetes. Many additional complications 
that reduce the exercise capacity, such as 
microvascular diseases that induce retinopathy, 
nephropathy, and neuropathy are also often present 
(McMillan, 1979). A discussion follows on those 
factors believed to be responsible for decreasing 
exercise performance in diabetics, especially as 
related to the specific fitness categories of body 
composition, cardiovascular capacity, muscular 
strength and endurance, and flexibility.
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Diabetes, Exercise, and Body Composition
The initial discovery of hyperinsulinemia in the 
type II diabetic by Berson and Yalow (Sherwin and 
Felig, 1978) was surprising until it was later 
discovered that obesity itself causes hyperinsulinexnia 
with an accompanying reduction in insulin resistance 
(Sherwin and Felig, 1978; Stout, 1981). This 
resistance, which has been correlated to a reduction 
in insulin receptors within fat cells (Cooppan and 
Flood, 1985), increases the demand for insulin. In 
the diabetic, however, the defective beta cell 
function of the pancreas will prevent an adequate 
increase in insulin and, consequently, the deficient 
secretory mechanism will be recognized. Obesity has, 
therefore, been labeled as a "diabetogenic factor" 
(Cooppan and Flood, 1985).
Whether obesity itself can be called a major risk 
factor for developing coronary artery disease (CAD) 
remains questionable. Most of the epidemiologic data 
that has been assessed using multivariate analyses has 
lead to the conclusion that obesity is not a separate 
risk factor. However, Keen et al. (cited by Leland 
and Maki, 1985) noted a study showing an increased 
incidence of angina in an obese population that was 
otherwise matched to all other risk variables.
Obesity has more frequently been associated with
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inducing other major risk factors such as hypertension 
and increasing the levels of cholesterol and 
triglycerides (Cooppman and Flood, 1985), subsequently 
causing large vessel abnormalities (Stout, 1981). 
Therefore, any deleterious effect on exercise caused 
by obesity appears to be an indirect one.
The occurance of obesity in diabetes has been 
claimed to be approximately 75 to 85% in the type II 
diabetic (Mazzaferri, 1986; Kahn, 1985; Guthrie and 
Guthrie, 1982) whereas the Type I diabetic is normally 
associated with weight loss, especially during periods 
of poor control (Davidson, 1986).
Although it is generally accepted that the 
incidence of hypertension is increased in the diabetic 
(McMillan, 1979; Coram and Mangum, 1986; Christlieb, 
1985), conflicting data has been reported. Ganda 
(1985) cited 5 studies in which diabetes was strongly 
related to hypertension and 2 which failed to show 
such a correlation.
Data from the Framingham study (Kannel and McGee, 
1979) have provided evidence for the conculsion that 
obesity is associated with hyperlipidemia and low 
HDL-cholesterol (HDL-C) levels. HDL-C levels have, 
alternately, been shown to be inversely related to 
coronary disease (Nikkila, 1981). Numerous studies as 
mentioned by Coram and Mangum (1986) when comparing
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diabetes and hyperlipidemia have, however, produced 
conflicting results. These will be mentioned in the 
discussion of cardiovascular capacity. The results, 
however, appear to be dependent upon the present state 
of metabolic control, type and severity of diabetes, 
sex and other factors.
It cannot presently be concluded that the reduced 
exercise capacity of diabetics is influenced by 
obesity itself, however, obesity is strongly related 
to other risk factors that have deleterious effects on 
exercise. It is well known that obese individuals 
will not perform as well during strenuous physical 
activity as their age and sex matched lean 
counterparts (Katch and McArdle, 1983). The same 
relationship is expected to occur between obese 
diabetics and lean normal subjects. However, if the 
obese diabetics have no additional risk factors and if 
the diabetes is well controlled, it is questionable as 
to whether their physical performance would differ 
significantly from their age, sex and weight matched 
normal counterpart. Given that the largest majority 
of type II diabetics are obese (Kahn, 1985; 
Mazzafferri, 1986; Davidson, 1986; Guthrie and 
Guthrie, 1982) and that many of them develop 
additional risk factors and complications, it seems 
reasonable to predict that their physical capacity
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would be lower than their age and sex matched 
non-diabetic counterparts.
Cardiovascular Capacity and the Diabetic
Diabetics are known to have more coronary risk 
factors than the normal population, leading to a 
higher incidence of CAD, greater atherosclerotic 
involvement and more myocardial infarctions (MI)
(Coram and Mangum, 1986). Brownlee (1985) has stated 
that because of the increased atherogenesis, diabetics 
have a 2-fold greater risk of developing CAD and 
stroke (CVA— cerebral vascular accident) than the 
normal population and a 3 to 4-fold greater chance of 
developing symptomatic peripheral arterial disease 
which generally manifests itself as nephropathy, 
retinopathy, and/or neuropathy. These conditions, 
either when present singly or in combination, cause a 
reduction in both maximum oxygen consumption and in 
oxygen delivery to the tissues, thereby decreasing the 
exercise performance capacity of the diabetic. Two 
main categories of diseases, macroangiopathy and 
microangiopathy, form the basis of classification for 
many of the cardiovascular complictions of diabetes.
Macroangiopathy. According to Ganda (1980), 
macrovascular disease (atherolsclerosis) that 
primarily manifests itself as a cardiovascular 
disorder accounts for approximately 75% of all
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diabetic deaths, and it is not restricted to either 
type of diabetic. It is more prevalent in the Type II 
diabetic between the ages of 50 and 70, and it is 
observed with equal prevalence in both male and female 
diabetics. This finding is discordant with the normal 
populaton in which women have been shown to possess a 
degree of protection against arterial diseases 
(Schneider, Vitug et al., 1986), presumably due to an 
inhibitory effect of estrogens on atherosclerosis 
(Stout, 1981).
LDL-C Levels. There is strong evidence 
linking atherosclerosis to elevated plasma lipid 
levels, especially when considering total serum 
cholesterol concentrations and low density 
lipoproteins (LDL) (Ganda, 1980). In addition, 
independent plasma triglycerides have been labeled a 
risk factor for CHD by several investigators 
(Schneider, Vitug et al., 1986). Although never 
adequately shown, the increased CAD and other 
atherosclerotic vascular diseases associated with 
diabetes have frequently been attributed to the 
abnormal metabolism of lipoproteins (Nikkila, 1981). 
Triglycerides, very low-density lipoproteins (Nikkila, 
1981), and plasma fatty acids (McMillan, 1981) are 
regularly elevated in diabetes, but there is no 
general agreement that these are responsible for the
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increased incidence of CAD. As reported by Coram and 
Mangum (1986), there is conflicting data as to whether 
the LDL-C levels are increased, decreased, or constant 
when comparing diabetics to the normal population.
One study reported continually high LDL-C levels; 
another reported high LDL-C levels only during periods 
of poor metabolic control in Type I diabetics; the 
levels were reported to be high in males but not in 
females in yet another study; and there were two 
reports showing no difference between diabetics and 
the apparently healthy population. These studies, 
again, indicate that this ratio may change depending 
upon the type and severity of the diabetes, glycemic 
control, metabolic profile, sex, and/or other factors.
HDL-C Levels. High density lipoprotein 
(HDL-C) levels, on the other hand, have been shown to 
have a strong inverse relationship to both the 
incidence and the severity of atherosclerotic disease 
(Nikkila, 1981). Researchers, however, do not agree 
on the HDL-C levels found in diabetics. Nikkila 
(1981) has proposed an explanation for the conflicting 
evidence in that HDL-C concentrations are based on the 
insulin levels and on the insulin sensitivity of the 
tissues. He found that Type I diabetics with moderate 
to good control, had HDL-C levels in the high normal 
range. The levels in the Type II diabetic were
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similar to non-diabetic matched subjects but lower 
than the Type I diabetics. Those showing low HDL-C 
levels displayed advanced renal involvement, repeated 
periods of ketoacidosis, or excessively high 
triglyceride and uric acid levels. From this he 
suggested that perhaps 9II the excessive CAD noted in 
the diabetic population originates in this subgroup of 
diabetics. There appears to be a definite need for 
further investigation into the role of plasma lipids 
and their relationship to atherosclerotic disease in 
the diabetic population before concrete conclusions 
can be drawn.
Atherogenic Agents. Excessive insulin has 
recently been identified as a potential atherogenic 
source (Schneider et al., 1986). It has been linked 
to atherosclerosis through both clinical and 
epidemiologic evidence and through biological 
evidence. Three prospective studies, as referred to 
by Stout (1981), all showed that increased plasma 
insulin levels, independent of other major risk 
factors, were positively related to the development of 
CAD. He also noted the concentrations could even have 
a predictive value. Schneider et al. (1986) 
additionally referred to more than 20 studies showing 
a similar relationship.
Numerous animal studies showed that insulin 
concentrations correlated to lipid inflitration and 
deposition, glucose incorporation, and smooth muscle 
proliferation in arterial walls (Stout, 1981). These 
biologic factors are believed to play a major role in 
the development of atheromatous lesions. Ross and 
co-workers have established that the hallmark of 
atheromatous lesions is the deposition of lipids in 
the smooth muscle cell, and that the proliferation of 
the smooth muscle is the initiator and perpetuator of 
the fibrous plaque (Ganda, 1980).
Additional support for the positive association 
between insulin levels and atherosclerosis comes from 
Stout (1981). He found the following: lipid
containing lesions, not associated with weight change 
or lipid level changes, were noted in the aortas of 
chickens following 19 weeks of insulin administration; 
experimental atherosclerosis in cholesterol-fed 
rabbits was reduced following insulin-secreting tissue 
ablation and it returned to the original atheromatous 
state upon treatment with insulin, and; progressive 
smooth muscle proliferation was noted in monkey cells 
exposed to increasing levels of insulin.
Other possible atherogenic agents have been 
purposed. Growth hormone (GH) levels are known to be 
higher in both the fasting and the post-glucose fed,
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uncontrolled Type I diabetic as well as in the Type II 
diabetic. A study by Merimee (Ganda, 1985) showed 
that dwarfs who had deficiencies in GH were resistant 
to atherosclerosis, even though they were not 
resistant to developing diabetes. Catecholamines have 
also been incriminated as atherogenic agents, and 
increased concentrations of these are often seen in 
uncontrolled diabetes (Wasserman and Vranic, 1984).
Although diabetes is caused by either a relative 
or absolute insulin deficiency, this does not 
necessarily mean that low insulin concentrations are 
present. As previously stated, obesity itself is 
associated with high insulin levels, and, 
consequently, obese Type II diabetics have higher 
concentrations than the non-diabetics who are thinner. 
In the insulin-dependent diabetic, the administered 
daily dose of insulin is considerably greater than the 
normal pancreatic secretion, and, consequently, the 
concentration in the Type I diabetic is also often 
higher than in the non-diabetic. According to Stout 
(1981), only two studies comparing atherosclerosis to 
insulin levels in the diabetic population had been 
completed prior to 1981. These both, however, showed 
that insulin concentration had a direct effect on 
atherosclerosis.
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Based on the above research, a critical area for 
further investigation is to determine whether reduced 
insulin levels will prevent or diminish the 
development of atherosclerosis. Professed methods of 
accomplishing the diminution of insulin include weight 
loss, regular physical exercise and a better method of 
controlling exogenous insulin administration so that 
it is more in keeping with the normal physiologic 
response (Stout, 1981).
Microanqiopathy. The chances of becoming blind 
are 25 times greater in the diabetic population than 
in the normal one; chronic renal failure has a 17 
times higher frequency in diabetics; and a higher 
incidence of motor, sensory and autonomic nerve 
impairment are seen in the diabetic (Brownlee, 1985) . 
These three areas represent the main classification of 
microangiopathy and are related to the pathologic 
conditions of retinopathy, nephropathy and neuropathy, 
respectively. Miocroangiopathy is specific to the 
diabetic and is characterized by anatomical and 
functional changes in the basement membranes of 
capillaries and in the walls of arterioles and venules 
(Coram and Mangum, 1986), with the functional 
alterations preceeding the structural changes 
(McMillan, 1979). This distrubance in the 
microcirculation causes a relative tissue hypoxia, and
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therefore, diabetics thus affected have a lower 
maximal exercise ability. The microvascular 
alterations are believed to be due to a variety of 
hematologic abnormalities.
Hematologic Abnormalities. Hematologic 
abnormalities are associated with a decrease in tissue 
oxygenation and diabetes. They include decreased 
erythrocyte (RBC) deformability, increased hemoglobin 
content, and increased blood viscosity (Brownlee,
1985). Erythrocytes often travel through capillaries 
much smaller than their own diameter so they must have 
the ability to rapidly deform and reform upon entering 
and exiting the capillary, respectively. By 
aspirating RBCs from diabetics and normal controls 
into micropipets of 4 micometers, it was shown that a 
regular and unique impairment of RBC deformability 
occurred in diabetics (McMillan, Utterback et al., 
1978). The lack of deformability is suspected to 
create an impairment of maximal blood flow during 
exercise, and may also have a direct -relationship on 
the increased blood pressure response often observed 
in exercising diabetics.
Approximately 5 to 10 % of the total hemoglobin 
content in normal adult RBCs is comprised of minor 
hemoglobin species (Brownlee, 1985). Patients with 
uncontrolled diabetes exhibit a 2 to 3-fold increase
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in these minor hemoglobins, with the quantity 
reflecting the degree of hyperglycemia. These 
glycosylated hemoglobins, especially the Hb Ale 
species, have a high affinity for oxygen, thereby 
reducing the oxygen release and subsequent delivery to 
the tissues (Coram and Mangum, 1986).
Decreased serum albumin, increased globulins 
(McMillan, 1981) and increased fibrinogen (Brownlee,
1985) have been identified as the primary cause of the 
increase in blood viscosity noted in diabetics. The 
fibrinogen increase also enhances RBC aggregation. 
These factors, in addition to the lack of 
deformability cause an increase in the flow resistance 
of whole blood which ultimately leads to increased 
work for the heart and a reduction in oxygen delivery.
Although other hematologic abnormalities such as 
increased erythrocyte aggregation, leukocyte cell host 
defense response impairment, cell surface changes, and 
increased platelet adhesion are observed in diabetics, 
their relationship to microangiopathy are presently 
unclear, and further research in these areas is highly 
suggested (Brownlee, 1985).
Effects of Angiopathy on the Performance 
Capacity of Diabetics. Diabetics with angiopathy tend 
to exhibit higher blood pressure responses to 
exercise, reduced maximal heart rates, lower maximal
cardiac outputs (McMillan, 1979), and lower maximal 
oxygen uptakes (Murphy et al., 1981). The RBC lack of 
deformability, increased Hb Ale content, increased 
viscosity of the blood, and general thickening of the 
capillary basement membranes individually and 
collectively reduce oxygen delivery to the tissues.
It has been suggested that this impaired delivery 
forces the muscle cells to undergo more anerobic 
metabolism, thus producing the higher lactate and 
pyruvate levels observed in diabetics.
A study in which the functional capacity of 
diabetic-induced rats without insulin replacement was 
compared to diabetic-induced rats on insulin and to 
normal control rats concluded that those diabetic rats 
without insulin had significantly lower maximal V02 
than either of the other groups (Murphy et al., 1981). 
Additionally, as the condition became more severe, the 
rats showed a lower submaximal and maximal HR response 
to the same intensity of exercise than they had shown 
prior to becoming diabetic. This finding contradicts 
the normally observed higher resting and exercise HR 
found in both untreated and treated diabetics.
However, McMillan (1979) reported that Christensen et 
al. observed the same response in human subjects with 
long duration diabetes. This controversy appears to 
reflect the degree of diabetic control and the
duration of the disease. It is supported by the 
finding that insulin therapy in the rats appeared to 
reverse the abnormal responses, although not to quite 
to their same pre-diabetic level. An impaired 
sympathetic drive of the heart due to diabetic 
neuropathy is believed to be responsible for this 
response. Murphy et al. (1981) reported that 
Giachetti observed significantly decreased 
norepinephrine concentrations in those sympathetic 
nerves innervating the heart in one study. One 
extremely important finding in this experiment was 
that the normal linear relationship between V02 and HR 
was not maintained in the diabetic rat without insulin 
(Murphy et al., 1981). Therefore, it may be possible 
that submaximal testing in which submaximal HR are 
used to predict max V02 will result in erroneous 
information in this population. Further investigation 
in this area is indicated.
The exercise induced rise in systolic and 
diastolic blood pressure in the presence of 
microvascular changes, as reported by McMillan (1979), 
could severely stress the occular vessels, provoking 
hemorrhage. Consequently, diabetics with retinopathy 
should be cautioned about exercise, and it should 
perhaps be limited to isotonic low resistance exercise
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using the larger muscle groups (Coram and Mangum,
1986).
Exercise causes a redistribution of blood flow in 
the normal individual. In order to provide for 
adequate flow to working muscles, a compensatory 
reduction in both flow and volume occurs in the 
splanchnic area as well as in the kidneys (Coram and 
Mangum, 1986). Total blood volume, however, was shown 
to increase as a result of prolonged physical training 
(Oscai et al., 1968). The redistribution and blood 
volume reduction are even more drastically altered in 
those diabetics with microangiopathy as this condition 
favors protein and water loss from the plasma thereby 
reducing cardiac output (McMillan, 1979). Less blood 
is shunted to the viscera possibly creating renal 
corticol ischemia in the diabetic with advanced 
nephropathy. This may result in acute renal 
insufficiency; therefore, exercise should also be 
indicated with caution in this situation.
Muscular Strength and Endurance and the Diabetic
Published data specifically comparing muscular 
strength and endurance between the diabetic and the 
apparently healthy individual are extremely sparce.
As previously indicated the majority of the research 
performed on fitness levels in the diabetic population 
have been centered around physcial working capacities
in Type I diabetics. One study was identified, 
however, in which handgrip strength and local muscular 
endurance comparisons were made between young Type I 
diabetic boys and girls and normal age-matched boys 
and girls (Hebbelinck et at., 1974). The results 
indicated that there were no significant differences 
between the diabetic and non-diabetic groups on 
handgrip strength. Muscular endurance, however, as 
expressed by a thirty seconds sit-ups test, revealed 
significant differences in both male and female 
diabetic children.
Muscular strength, as determined by the size of 
muscle is dependent primarily upon heredity, 
testosterone levels, and the degree of physical 
training (Guyton, 1986; Katch and McArdle, 1983).
Males with greater concentrations of testosterone who 
are physically trained (strength related training) 
will have larger muscle cross-sectional areas than 
those with lower concentrations of testosterone who 
are matched on the other variables, thus enabling 
greater contractile forces within the muscles (Guyton,
1986).
There is no evidence suggesting lower than normal 
levels of testosterone in the diabetic, although 
higher than normal levels have been encountered 
following exercise (Vignati and Cunningham, 1985) in
this population. The significance of these higher 
levels, however, is unknown. Additionally, there is 
no evidence suggesting that the muscular strength of 
the diabetic cannot be increased with strength 
training as it can be in the normal subject. The data 
are far too limited to speculate on the effect of 
diabetes on muscular strength. However, considering 
the results of the Hebbelinck et al. study and the 
fact that no associated deleterious physiologic 
responses have been identified, there appears to be no 
reason why strength itself would differ significantly 
in the diabetic population, provided all other 
variables were similar. Those diabetics, however, 
with proliferatiave retinopathy, hypertension and 
other cardiovascular disorders should avoid performing 
heavy resistance exercises that elicit excessive 
intra-abdominal pressures, as this could worsen their 
condition (Vignati and Cunningham, 1985; Coram and 
Mangum, 1986) .
Muscular endurance, on the other hand, is 
directly related to the muscle's nutritive support, 
and primarily upon the amount of glycogen stored prior 
to exercise (Guyton, 1986). As previously noted, 
muscle glycogen, in the well controlled diabetic is 
within or just slightly below the normal range 
(Bjorkman, 1986). If this were the only factor
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responsible for endurance then, it would be possible 
for the diabetic's performance to be similar to the 
normal individual's. This, however, is not the case.
Christensen, as reported by Gollnick and Hodgson 
(1986), found that endurance-trained normal subjects 
had higher endurance capacities than those who were 
untrained primarily because the trained muscles 
exhibited an increased ability to oxidize a higher 
percentage of fats. This allows for a reduction in 
the glycogen depletion rate, thus enabling muscular 
work to be performed for longer periods of time. The 
mechanism responsible for this is associated with an 
increase in both the quantity and the size of muscle 
mitochondria (Holloszy, Dalsky et al., 1986), which 
has, in turn, been associated with an increase in 
oxygen utilization. Endurance training in normal 
subjects also results in lower concentrations of 
lactate in the blood and muscles. Lactate has been 
strongly associated with muscle fatigue as it is 
believed to have a negative effect on the contractile 
elements within the muscle (Astrand and Rodahl, 1977).
Diabetics also, typically, exhibit an increased 
oxidation of fatty acids during exercise, however, as 
indicated by Murphy et al. (1981), a study by 
Armstrong and co-workers showed decreases in the 
mitochondrial protein concentrations in diabetes
induced animals with consequent reductions in maximal 
V02 and performance time. Additionally, diabetics 
have increased lactate levels both at rest and at 
exercise, potentiating early muscle fatique (Bjorkmain,
1986). Poorly controlled diabetic rats showed lower 
maximal V02 than either.the well controlled diabetic 
rats or the normal rats (Murphy, 1981). Holloszy et. 
al. (1986) also found that capillary density did not 
increase with training in the Type II diabetic. 
Increased capillary density, being a normal adaptation 
to exercise training, provides for an increase in fuel 
and oxygen delivery to the working muscles. Based on 
these findings, it is speculated that the endurance 
capacity of the diabetic will be lower that of the 
normal individual, and that the diabetic will not be 
able to effect the same degree of increases in 
endurance with training as seen in the normal 
individual.
Flexibility and the Diabetic
Flexibility, being defined as the possible range 
of motion within a joint or in a series of joints 
(deVeries, 1980) is one of the four main components of 
physical fitness. Although it is generally used in 
the determination of the overall fitness rating, less 
emphasis seems to be placed on this area when compared 
to the other areas of body composition, cardiovascular
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fitness, and muscular strength and endurance. A 
review of the literature indicates that there have 
been no studies specifically comparing flexibility 
between the diabetic and the apparently healthy 
individual.
Flexibility appears to be more related to the 
grace and finesse with which a sport or activity can 
be performed rather than to the performance of the 
activity itself. Of course, there are exceptions in 
that sports such as competetive diving, hurdling, and 
ballet will probably not be undertaken by individuals 
who exhibit inflexibility in those joints critical to 
the performance of the specific sport.
The range of motion limitations in any joint are 
set by such mechanical and physical factors as the: 
bony structure; muscles; connective tissue, including 
liagments and tendons; and the skin surrounding the 
joint. Diabetes does not appear to have an 
unequivocal effect on any of these structures.
However, the complications so often encountered in 
diabetes, particularly neurological disorders and 
obesity may play a role in reducing joint flexibility. 
Diabetic neuropathies have most commonly been 
associated with atrophy of the interosseous 
musculature of the hands and feet and neuroarthropathy 
of the tarsometatarsal joints, causing decreased
mobility and flexibity in these areas (Podolsky and 
Marble, 1985). The excess quantity of fat in the 
obese diabetic may also cause a reduction in 
flexibility simply due to physical restriction. It 
is, therefore, speculated that the presence of 
diabetes with an absence of other complications should 
have no significant effect on flexibility of joints. 
Benefits of Exercise for the Diabetic
The mechanisms responsible for the benefits 
produced by exercise are as of yet not completely 
understood in either the diabetic or the healthy 
individual. However, there is little doubt that 
through a conscientious program of regular exercise, 
the apparently healthy individual can demonstrate 
improvement in all areas of physical fitness providing 
the training is performed with adequate frequency, 
duration and intensity (Astrand and Rodahl, 1977).
The area of special importance is in improving 
cardiovascular fitness, and reductions in several risk 
factors associated with macroangiopathy have been 
observed in the normal population. The primary 
physiologic changes observed include: reductions in
blood lipids, blood pressures, and resting and 
exercise HR; increases in maximal oxygen consumption 
and peripheral vascular circulation; and improved
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insulin sensitivity and glucose tolerance (Vignati and 
Cunningham, 1985).
It is reasonable to assume that some of the same 
benefits to the cardiovascular system exhibited in the 
general population will also occur in the diabetic 
population, and physical training has been shown to 
reduce some of the risk factors associated with 
artherosclerosis (Vignati and Cunninghan, 1985;
Richter and Galbo, 1986; Devlin, 1986; DiNovis, et 
al., 1985; Coram and Mangum, 1986). The primary 
determing factor as to whether the diabetic can 
benefit from habitual exercise appears to be related 
to the state of metabolic control (Bergman and 
Auerhahn, 1985). Exercise may even be a "perturbation" 
to metabolism in the poorly regulated, Type I 
diabetic. One of two responses are likely to occur in 
this situation, either an increase in hyperglycemia or 
an exercise induced hypoglycemia.
As summarized by Richter and Galbo (1986), if the 
pre-exercise insulin levels are low, an exaggerated 
exercise induced increase in the counter-regulatory 
hormones occurs causing hepatic glucose output to 
increase. Additionally, the uptake of glucose in the 
muscles is impaired due to a lack of insulin-effect as 
well as to the inhibiting effect of the increased FFA, 
ketone bodies and catecholamines that normally
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accompany the insulin deficient state. Increased 
hyperglycemia subsequently results. The dangerous 
condition of diabetic coma is also possible during 
exercise in the insulin deficient state as this 
enhances lipolysis and FFA metabolism which, in turn, 
enhances ketone production (Vignati and Cunningham, 
1985). Exercise is, therefore, contraindicated when 
the diabetic is in a ketogenic state.
Hypoglycemia, on the other hand, is likely to 
occur in the insulin-dependent diabetic with increased 
concentrations of insulin either because of enhanced 
absorption from the injection site or to high plasma 
levels from a previous injection. These high levels 
create a situation whereby the hepatic glucose 
production is decreased and the muscle glucose uptake 
is increased, possibly potentiating neurological 
disorders associated with hypoglycemia such as 
confusion, irritability, and coma (Bergman and 
Auerhahn,1985; Richter and Galbo, 1986).
Physical training has been shown to produce the 
following benefits in the well controlled Type I and 
in the Type II diabetic: increased insulin
sensitivity; decreased plasma glucose concentrations; 
improved lipid profile, including lower cholesterol 
and triglyceride levels and higher plasma HDL levels; 
decreased blood pressures; increased maximal V02;
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decreased obesity; and increased sense of well-being 
(Devlin, 1986; Vignati and Cunningham, 1985).
Although conflicting data exists on the ability 
of exercise to enhance glycemic control, Vignati and 
Cunningham (1985) refer to studies of Type II 
diabetics in which regular programs of moderate 
exercise (greater than 50% max V02) resulted in 
uniformily improved glucose tolerance, whereas acute 
short-term exercise resulted in a decrease in glucose 
tolerance. It is fairly well accepted that habitual 
exercise improves insulin resistance in both diabetic 
types providing good control is maintained, thus 
possibly allowing a reduction in the daily dose of 
insulin or oral hypoglycemic agents (Bergman and 
Auerhahn, 1985).
Summary
As was discussed, diabetes mellitus is an 
extremely complex syndrome causing alterations in the 
normal metabolism of carbohydrates, fats, and proteins 
both at rest and during exercise. The complications 
generally associated with this disease create 
additional impairments in the functional ability of 
the diabetic individual. The consequences of these 
abnormalities vary depending upon the severity and 
state of control, however, it is quite probable that
60
the physical performance of the diabetic individual 
will be less than that of the apparently healthy 
individual.
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CHAPTER 3 
Methodology
The benefits of exercise as a therapeutic agent 
for the type II diabetic have long been realized, 
however, current knowledge in establishing training 
programs is quite inadequate. The purpose of this 
study was to compare the fitness levels of type II 
diabetics with those of an apparently healthy 
population. If proven to be different, norm tables 
should be designed specifically for the diabetic 
population in order provide a solid foundation for the 
development of safe and effective exercise programs.
Although the data collected at the University of 
Nevada at Las Vegas (UNLV) was an independent venture, 
the same study was also performed at both the 
International Diabetes Center in Minneapolis,
Minnesota and at the Alvarez Diabetic Center in 
San Diego, California. The data from all three 
locations will be compiled and used in the final 
analyses.
In addition, an independent study measuring pre 
and post exercise blood glucose levels was performed 
at the same time on the UNLV subjects. Although there 
may be reference to this study, especially in the
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questionnaires and letter of explanation to the or 
subjects, the data accumulated will not be presented 
or discussed in this paper.
Experimental Design 
Each volunteer, after receiving medical clearance 
agreed to be tested according to the procedures 
described in The Y/s Wav to Physical Fitness (Golding 
et al., 1982) in the following four fitness 
categories: body composition; cardiovascular
endurance; flexibility; and muscular strength and 
endurance. All data was assembled and analyzed 
according to age and sex and then compared to the norm 
tables established by the YMCA for the apparently 
healthy population (Golding et al., in press).
Subj ects
Only the subjects tested at UNLV will be 
described in this section. With the assistance of 
several local physicians, potential type II diabetic 
subjects were identified and a letter of explanation 
was sent to each (Appendix A). Those who expressed 
interest in participating were asked to be subjects 
providing they received medical approval from their 
primary care physician. The subjects were 12 adult 
males ranging in age from 53 to 69 and 14 adult
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females between 41 to 67 years of age. The 
descriptive data of this diabetic population are 
summarized in Appendix E.
Additionally, there were 126 male and 74 female 
diabetic subjects from the other testing centers for a 
total sample size of 138 males and 88 females. The 
number of males and females included in the YMCA norm 
tables were 2271 and 2008, respectively. They 
represented the same age group as the diabetic sample.
Procedures
All subjects reported to the laboratory in 
exercise clothing at a time convenient to their 
schedules. They had been instructed earlier to follow 
their normal daily routine of eating, sleeping and 
taking medications but to refrain from smoking for at 
least two hours prior to the testing. It was also 
suggested that for their comfort they not eat a large 
meal immediately before exercising.
The purpose, procedures, risks and benefits were 
explained and each subject signed an informed consent 
form (Appendix B).
Upon the completion of a medical history and 
physical activity questionnaire (Appendix C), the 
actual testing was explained and performed in the 
following manner:
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Sitting Heart Rate and Blood Pressure
The sitting heart rate and blood pressures were 
recorded while the subject remained seated with both 
feet flat on the floor using the following techniques 
and equipment:
1. heart rates were determined by counting 
the pulse for one full minute with the aid of a 
stethescope.
2. left arm systolic and diastolic blood 
pressures were measured in the standard manner 
using a sphygmomanometer and a stethescope.
Standing Height and Weight
The height in centimeters (cm) and the weight in 
kilograms (kg) were measured using the standard 
physician's scale allowing the subject to remain 
clothed but without shoes.
Pre-test Blood Glucose Determination
At this point, the pre-exercise blood glucose 
level was measured for the independent study using the 
blood glucose meter and the Chemstrip bG reagent 
strips.
Skinfold Measurements
Skinfold measurements were performed to determine 
percent subcutaneous fat distribution using the 
Harpenden skinfold calipers graduated to 0.2mm. The 
sites used included:
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MEN
chest
WOMEN
thigh
abdomen abdomen
ilium
tricep
ilium
tricep
scapula
thigh
scapula
The estimation of percent body fat was calculated 
according to the new Jackson and Pollock equations 
(unpublished data) based on the sum of four skinfold 
measurements (abdomen, ilium, tricep, and thigh) for 
both men and women. The formulae are listed below:
Trunk Flexion Flexibility
The trunk flexibility measurement was then 
obtained in the following manner:
1. the subjects were allowed to perform 
slow, non-ballistic stretching exercises for a 
few minutes while the actual procedure was 
explained and demonstrated.
2. they then sat on a specially designed 
flexibility board with their hips flexed, knees 
extended and arms outstretched between their 
legs with one hand on top of the other.
Percent Body Fat— Sum of Four
MEN % Fat = -5.76377 + 0.29288 (£.4)
2- 0.0005 (£.4 ) + 0.15845 (Age)
WOMEN % Fat = 1.40724 + 0.29669 (£.4)
- 0.00043 (£.4 2 ) + 0.0293 (Age)
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3. they were then instructed to slowly 
reach forward as far as possible along the ruler 
on the board and to hold that position 
temporarily while the testor mentally recorded 
the distance. They were encouraged to keep 
their trunk straight, and to insure that their 
lower legs remained extended, the testor held 
their knees down.
4. the best of three trials was recorded to 
the nearest one-half inch (in).
Three-Minute Step Test
The three-minute step test was performed to 
measure cardiorespiratory fitness using the following 
equipment and procedures:
1. a timing clock was set for three minutes 
and a recovery clock for one minute.
2. a calibrated metronome was set at 96 
beats per minute (bpm) which is equivalent to 24 
steps per minute on a 12-inch bench.
3. the one-minute recovery heart rate was 
obtained using a stethescope.
4. the procedure was explained and 
demonstrated.
5. the clock was turned on as the 
subject began stepping and continued for three 
minutes.
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6. at the end of stepping, the subjects sat 
on the stepping bench.
7. the one-minute recovery heart rate 
started within 5 seconds of the cessation of 
stepping.
8. the score, was recorded as the total 
1-minute recovery HR.
Muscular Strength and Endurance
Muscular strength and endurance was measured by 
both the bench press and the one-minute timed situps. 
The bench press was performed as follows with males 
using an 80-pound barbell and females using a 35-pound 
barbell:
1. the procedure was explained and 
demonstrated.
2. a metronome was set for 60 beats per 
minute and the subject reclined on a standard 
bench in the supine position with the feet 
firmly supported.
3. with elbows flexed, hands pronated and 
shoulder width apart, the barbell was given to 
the subject.
4. the barbell was pressed upward to full 
extension of the elbows on the first beat of the 
metronome and it was returned to the starting 
position on the second beat. This sequence was
repeated until the subject could either no 
longer maintain the rhythm or until full elbow 
extension could not be accomplished.
5. the maximum number of presses was 
recorded.
After explaining and demonstrating the one-minute 
timed situps, they were performed as follows:
1. the subject reclined in a supine 
position on an exercise mat with the knees bent 
and the hands clasped lightly behind the head.
2. the testor held the subject's feet down 
to provide stability.
3. when the clock was started, the subject 
began performing as many situps in one minute 
as possible. The situp was considered to be 
correct if the subject sat up, touched one elbow 
to the opposite knee (the opposite elbow and 
knee were used during the next situp), and then 
returned to the starting position.
4. the maximum number of situps was 
recorded.
Submaximal Bicycle Ergometer Test
A submaximal bicycle test, another indicator of 
cardiovascular fitness, was performed using the 
following equipment and procedures:
1. a Monark bicycle ergometer.
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2. the YMCA"S "Guide to setting workloads" 
for males and females (Golding et al., 1982).
3. a Microcore portable ECG monitor and
electrodes for recording the heart rate.
4. metronome set at 100 beats per minute to 
provide a speed of 50 rpm throughout each 
workload.
5. timing clock.
6. each subject was connected to a CM-5 ECG 
lead for the purpose of recording heart rates 
during each stage, rather than using the heart 
rate conversion chart listed in the Y's test 
battery.
7. the procedure was explained and 
demonstrated, and the subject mounted the 
bicycle.
8. the metronome was turned on and the 
subject was asked to begin pedalling with no 
resistance in order to synchronize the beat and 
the pedalling. This was assured if each foot 
was at the same position relative to the 
crankshaft with each beat of the metronome.
9. the test was initiated by applying a 
resistance of 150 kgm to the bicycle ergometer 
in accordance with the Y's "Guide to Setting 
Workloads" while simultaneously starting the
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clock.
10. heart rates were recorded at the end of 
the second and third minutes of this workload, 
and if a steady-state heart rate was reached (no 
more than five beats per minute difference 
between each minute), the resistance was 
increased in accordance with the same 
guidelines.
11. this process continued until two 
workloads yielding steady-state heart rates with 
at least ten beats per minute difference were 
encountered, assuming that the first workload 
used resulted in a heart rate of at least 110 
beats per minute.
12. the results were recorded on the 
"Physical Working Capacity Test" sheets (Appendix
D) .
13. the electrodes were disconnected from 
the subject.
Post-test Blood Glucose Determination
The post-exercise blood glucose level for the 
independent study was then determined and recorded 
using the same procedures as before.
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Analyses of the Data
This study compared the fitness levels of Type II 
diabetics to the apparently healthy population. The 
four general fitness categories used for comparison 
were body composition, cardiovascular fitness, 
muscular strength and endurance, and flexibility. The 
subjects were grouped according to age and sex and the 
variability between both groups was determined for the 
following variables: weight; percent body fat;
sitting heart rate; sitting blood pressure (systolic 
and diastolic); one-minute recovery heart rate (bench 
step test); predicted maximum workload and VO 2 
(submaximal bicycle test); muscular strength and 
endurance (sit-ups and bench press); and trunk 
flexibility (Appendix E).
The null hypothesis is that the physical fitness 
level of Type II diabetics is no different from the 
apparently healthy population. The Z x test was used 
to determine whether any observed differences between 
the groups' means were statistically significant. An 
alpha level of p<0.05 was chosen.
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CHAPTER 4 
Results and Discussion
This study compared the physical fitness levels 
of male and female Type II diabetics, ages 40 and 
above, to apparently healthy subjects of the same age 
group. Raw data on the diabetics are presented 
(Appendix E) and the data on the diabetics from UNLV 
are identified separately as well as being included 
with the entire group of diabetics. Raw data on the 
apparently healthy populations are not presented.
Means and standard deviations were determined for all 
groups on the following variables: age; weight; %
body fat; 7 skinfold site measurements; resting heart 
rate (RHR); resting systolic and diastolic blood 
pressures (RSBP and RDBP respectively); trunk flexion 
flexibility; 3-minute step test; V02 max and PWC max 
predicted from the submaxmimal bicycle ergometer test; 
and muscular strength and endurance measurements as 
measured by the bench press and situps tests.
The data were treated with a two-tailed Z test of 
significant differences using the 0.05 level of 
significance. A significant difference was determined 
to exist if the absolute value of the Z "x (observed) 
was greater than or equal to the Z critical value of 
1.96. Tables 1 and 2 present the number of subjects
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(N), means, standard deviations and Z scores on male 
subjects, and tables 3 and 4 present the same 
information on female subjects. The results of each 
comparison will be presented and examined separately.
Age
Significant differences in age were encountered 
in both males and females with the diabetic subjects 
being older than the normal population (males 56 vs 
53; females 55 vs 53). Although a decline in physical 
working capacity is associated with the aging process, 
it is doubtful that these small differences in age 
would be of any practical significance. Astrand and 
Rodahl (1977) noted only a 0.3 liter reduction in V02 
max over a ten year period in non-active subjects 
between the two age groups of 50 to 59 and 60 to 69. 
When expressed as milliliters of oxygen per kilogram 
of body weight, the difference over a two or three 
year period (differences noted in the diabetic groups 
over the normal subjects) would probably be 
insignificant. Other studies indicate the average 
rate of decline in V02 max for non-active men is 
approximately 0.40 to 0.45 ml* kg _1min _1per year and
0.30 ml * kg -1 min-1per year for sedentary women 
(Stamford, 1988). These represent reductions of less
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Table 1. Comparison of means between male 
diabetics and apparently healthy 
males (all variables except 
skinfold measurements)
DIABETICS APPARENTLY
HEALTHY
n T s N M. CT
Z
score
age 138 56 8.4 2226 53 9.3 3.80*
weight 136 196 29.8 2098 186 27.7 4.20*
% Fat 132 25 6.3 1932 24 5.6 0.21
RHR 138 75 11.9 2151 71 11.2 4.41*
RSBP 138 140 14.0 2177 129 14.7 8.80*
RDSP 126 85 8.9 2178 81 9.4 4.76*
Flexi­
bility 136 12 3.9 2101 12 5.2 0.00
3 min 
step 123 119 18.0 795 109 19.4 5.71*
bench
press 136 10 6.4 1534 13 8.8 0.40
situps 138 17 9.3 1989 23 10.6 6.65*
V02 max 122 32 11.4 1208 34 10.4 0.21
PWC max 121 1103 369.1 1220 1171 382.2 1.96*
♦significant difference at 0.05 level
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Table 2. Comparison of means between male 
diabetics and apparently healthy 
males (skinfold measurements)
APPARENTLY 
DIABETICS HEALTHY
_  Z
n X S N H. Score
chest 137 22 7.7 1918 20 8.7 2.70*
ab­
domen 132 32 13.5 1943 31 11.1 1.03
ilium 135 27 11.3 1944 24 10.3 3.39*
ax­
illa 137 22 8.0 1130 21 7.8 1.49
scap­
ula 136 23 8.4 1141 20 7.9 4.41*
tri­
ceps 133 12 5.6 1208 13 5.3 2.17*
thigh 136 16 6.8 1179 17 6.9 1.69
* significant difference at the 0.05 level
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Table 3. Comparison of means between female 
diabetics and apparently healthy 
females (all variables except 
skinfold measurements)
APPARENTLY 
DIABETICS HEALTHY
_  Z
n X s N M. cr Score
age 88 55 8.1 2000 53 9.1 2.06*
weight 87 174 36.3 1934 147 25.9 9.71*
% fat 80 33 6.7 1740 31 6.9 0.26
RHR 88 78 13.5 1929 72 10.3 5.45*
RSBP 87 135 12.8 1917 121 14.8 8.81*
RDBP 85 84 7.9 1936 77 9.6 6.73*
Flexi­
bility 87 15 4.3 1841 16 4.1 0.23
3 min 
test 73 123 18.7 627 117 18.8 2.73*
bench
press 84 15 8.7 1286 13 9.3 1.98*
situps 86 10 10.0 1491 16 9.5 3.92*
V02
max 83 26 6.5 1012 30 9.3 3.92*
PWC
max 84 767 203.1 1021 767 264.1 0.00
* significant difference at 0.05 level
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Table 4. Comparison of means between female 
diabetics and apparently healthy 
females (skinfold measurements)
APPARENTLY 
DIABETICS HEALTHY
  Z
n X s N M Score
chest 52 34 12.2 254 18 9.4 12.31*
ab­
domen 82 39 13.5 1764 31 11.8 6.15*
il­
ium 84 32 12.5 1761 23 10.8 7. 63*
ax­
illa 51 33 10.6 240 21 8.9 9. 60*
scap­
ula 87 28 9.2 1101 20 8.4 8.89*
tri­
ceps 88 27 9.0 1745 24 7.9 3.57*
thigh 86 34 10.0 1103 34 11.8 0.00
* significant difference at the 0.05 level
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than 1 percent per year, and would, therefore, be of 
no biological significance.
Weight and Percent Body Fat
Table 1 shows significant differences in body 
weight between male diabetics and normals (196 vs 186) 
with similar results for females in Table 3 (174 vs 
147). There were, however, no significant differences 
in percent body fat determined from skinfold 
measurements of 4 sites in either males or females 
(males 25 vs 24; females 33 vs 31). When comparing 
actual skinfold measurements (tables 2 and 4), 
numerous significant differences were noted between 
the groups. Male diabetics had significantly greater 
measurements at the chest, ilium, and scapula whereas 
the normals had a significantly higher tricep 
measurement. Normal males had a greater mean thigh 
measurement, but it was not significant. The female 
diabetics had significantly greater measurements at 
all sites except the thigh.
An increased body weight without a corresponding 
increase in percent body fat could be explained as 
either: (1) the diabetics had a higher percent of
muscle mass; or (2) the diabetics were significantly 
taller; and/or (3) the diabetics had a higher percent 
of deep body fat. An increased muscle mass seems
unlikely in the diabetic samples for two reasons. The 
loss of lean tissue has been associated with the aging 
process (Stamford, 1988), and the diabetics were 
significantly older. Although this age associated 
muscle loss can be diminished through chronic 
exercise, it is doubtful that the daily activity 
levels were substantially different between -the 
diabetics and the apparently healthy subjects. In 
addition, the very nature of diabetes with a lack of 
insulin promotes protein degradation and muscle 
atrophy.
If the diabetic subjects were significantly 
taller than the normal population, a greater weight 
would be expected without an associated increase in 
body fat. This variable was not analyzed, however, 
there appears to be no correlation between diabetes 
and height, thus no significant differences were 
expected to exist.
The third explanation of a greater percent of 
internal fat is the most reasonable since the altered 
lipid metabolism of diabetes often leads to fatty 
livers and hyperlipidemia. Skinfold calipers assume a 
constant relationship between subcutaneous fat and 
deep fat (Stamford, 1988). This relationship may not 
be applicable in the diabetic or in older subjects.
It is interesting to note that when comparing the 
mean percent body fat of the apparently healthy 
subjects from the new YMCA fitness norm tables 
(Golding et al., in press) to the mean ranking of the 
old YMCA fitness norms (Golding et al., 1982) for the 
age group 46 and older, significant increases have 
occurred during the past 6 years (t-test at p 0.05). 
The results showed that the percent body fat increased 
4 % in males (from 21 to 25 %) and 6 % in females 
(from 25 to 31 %).
Cardiovascular Variables
Resting HR. Male and female diabetics showed 
significantly greater resting mean heart rates than 
the apparently healthy populations (males 75 vs 71; 
females 78 vs 72). Since the resting HR is affected 
by so many factors such as age, sex, size, posture, 
ingestion of food, emotions, body temperature, 
environmental factors and smoking (deVries, 1980), 
predicitng physical performance based on heart rates 
is meaningless. However, it is known that the slower 
the heart rate, the greater the efficiency of the 
heart, all things being equal. Also, Astrand and 
Rodahl (1970) showed that individuals with larger 
stroke volumes and lower heart rates have a greater 
capacity for oxygen transport. These facts allow for
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a strong implication that the significantly higher 
heart rates observed in the diabetic samples lower the 
cardiac efficiency and oxygen consumption resulting in 
a decreased physical performance.
Resting systolic and diastolic blood pressures. 
The diabetic population showed significantly greater 
mean RSBP and RDBP than the normal subjects (males 
RSBP 140 vs 129, RDBP 85 vs 81; females RSBP 135 vs 
121, RDBP 84 vs 77). This supports the generally 
agreed upon fact that hypertension is approximately 
twice as common in the diabetics as in the 
non-diabetic population (Christlieb, 1985) . The 
diabetic males, with a mean RSBP of 140 mm Hg are 
considered to be borderline hypertensive, and the mean 
RSBP of the female diabetics is clearly at the upper 
limits of normal. High blood pressure causes an 
increased workload on the heart which is generally 
asociated with hypertrophy of the heart muscle. The 
accompanying coronary blood supply, however, does not 
increase as much as the actual increase in muscle 
mass. This ultimately leads to a relative ischemia 
(Guyton, 1986) and a reduction of cardiovascular 
capacity.
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Cardiovascular Fitness
Three-minute step test. The three-minute step 
test, an indicator of cardiovascular fitness based on 
a one-minute recovery heart rate resulted in 
significantly higher recovery heart rates for both 
male and female diabetics (males 119 vs 109; females 
123 vs 117). This indicates that the cardiovascular 
stress of bench stepping was significantly greater for 
the diabetics than for the normal population. Katch 
and McArdle (1983) additionally concluded that those 
subjects with higher recovery heart rates also tended 
to have lower maximal oxygen uptakes, again indicating 
a potentially decreased physical capacity in the 
diabetic subjects.
VO 2 max and PWC max. The submaximal bicycle 
ergometer tests showed conflicting results both within 
the test itself and to the one-minute recovery heart 
rate indication of cardiorespiratory fitness. Male 
diabetics had a significantly lower maximal working 
capacity, or PWC max (1103 vs 1171) without a 
corresponding decrease in V02 max (32 vs 34), whereas 
the female diabetics showed a significantly lower V02 
max (26 vs 30) without a corresponding decrease in PWC 
max (174 vs 174). The measures of V02 max and PWC max 
should parallel each other since both depend upon the 
individual/s ability to supply oxygen to the working
muscles. The discrepant findings in this study can 
best be explained as an error in measurement, for when 
prediction equations are used to predict one variable 
from another, any initial measurement error has the 
potential of becomming magnified during the 
derivation, thus invalidating the results. Without 
further investigation, a statement comparing the 
cardiorespiratory fitness of diabetics to normals 
based on the submaximal bicycle test is premature. The 
three-minute step test results, in this case, appear 
to be the most appropriate indicator of 
cardiorespiratory fitness as less measurement error is 
likely to exist.
Muscular Strength and Endurance
No significant difference in the number of bench 
presses was noted between the male diabetics and the 
normal males although the diabetics performed fewer 
repetitions (10 vs 13). The male diabetics performed 
significantly fewer situps (17 vs 23). The female 
diabetics performed a significantly greater number of 
bench presses than the normal females (15 vs 13). The 
results of the situps were the same as the males in 
that the female diabetics performed a significantly 
fewer number (10 vs 16).
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Since cross sectional areas and muscle mass were 
not measured in this study, it is difficult to 
speculate as to why the female diabetics showed 
superior upper body strength and endurance to the 
apparently healthy females. It has been observed that 
a heavier person may have greater total strength over 
a lighter one when lifting a heavy weight, but the 
lighter person may have greater strength per unit of 
body weight (Morehouse and Miller, 1967). Therefore, 
the fact that the female diabetics were 18 percent (27 
lb) heavier than the apparently healthy females may 
have had some impact on this finding. The male 
diabetics were also heavier, but only by 5 percent (10 
lb). This weight may not have been excessive enough 
to cause greater strength as observed in the female 
diabetics.
Trunk Flexion Flexibility
No significant difference was shown to exist in 
either the males or the females in the area of 
flexibility (males 12 vs 12; females 15 vs 16). As 
previously mentioned, this area of fitness was not 
assumed to reveal significant differences unless the 
diabetic individual had neurological disorders leading 
to inflexible joints.
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Percentile tables on all variables are located in 
Appendix E for comparisons between the diabetic 
population and the apparently healthy population.
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CHAPTER 5 
Summary and Conclusions 
Summary
This study was designed to compare the physical 
fitness levels of Type II diabetics to the apparently 
healthy population. The particular fitness categories 
of body composition, cardiovascular capacity, 
flexibility, and muscular strength and endurance were
I
examined using the Y's Way to Physical Fitness 
(Golding et al., 1982) battery of tests. Eighty-eight 
Type II diabetic females, ages 40 and above, (14 from 
the Las Vegas area and 74 from diabetic centers in 
Minneapolis and San Diego) were compared to 2,008 
apparently healthy female subjects, and 138 Type II 
diabetic males (12 from Las Vegas and 126 from the 
other centers) were compared to 2,271 apparently 
healthy males of the same age group.
Means and standard deviations were obtained on 
all groups for the variables of age, weight, percent 
body fat, resting heart rate (RHR), resting systolic 
and diastolic blood pressures (RSBP and RDSP, 
respectively), one-minute recovery HR (3 minute step 
test result), bench press, situps, and V02 and PWC max 
(submaximal bicycle test results), and flexibility.
The Z jc test was then used to determine whether
87
variability between the groups' means was 
statistically significant at the p^.0.05 level.
Significant differences were determined on 
several measurements in the female diabetics when 
compared to the apparently healthy females. These 
include greater: age; weight; RHR; RSBP; RDBP; 
one-minute recovery HR; and number of bench presses 
performed as well as a significantly lower number of 
situps performed. No significant differences were 
observed in flexibility or percent body fat (although 
all skin fold measurements except the thigh were 
significantly higher in the diabetic females).
Although significant differences were noted on the 
submaximal bicycle test no statement comparing 
cardiorespiratory fitness between the diabetic 
population and the normal population will be offered 
at this time as errors in measurements are believed to 
exist.
Significant differences were determined on 
several measurements in the male diabetic population. 
They, like the female diabetics, showed significantly 
greater age, weight, RHR, RSBP, RDPB, and one-minute 
recovery HR, and they performed a significantly fewer 
number of situps. No significant differences were 
noted in the number of bench presses, flexibility, or 
percent body fat. Conflicting data was also observed
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in V02 max and PWC max due to possible errors in 
measurements. Consequently, a statement on these 
variables seems premature.
Conclusion
1. Since no significant difference was observed 
in percent body fat in either diabetic group, it 
cannot be stated that Type II diabetics are fatter in 
this category. It should be noted that all groups are 
considered to have at least "marginal obesity" 
according to YMCA data (Golding et al., 1982). The 
mean percent body fat has increased significantly in 
both the male and female apparently healthy 
populations during the past 6 years. The males showed 
a 4 % increase from 21— 25 %, and the females showed a 
6 % increase from 25— 31% (Golding et al., in press).
2. Based on the findings of significantly 
greater RHR, RSBP, and RDSP, both male and female Type 
II diabetics have a reduced circulatory efficiency and 
a lower physical performance ability over the 
apparently healthy populations. This is supported by 
the significantly greater one-minute recovery HR in 
both diabetic groups.
3. Both the male and female diabetic populations 
performed a significantly fewer number of situps, and 
can, therefore, be considered to have weaker abdominal
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muscles. Although the female diabetics performed a 
significantly greater number of bench presses, it 
seems premature to classify them as the more fit 
group, as they had an additional 18 percent body 
weight to assist in the weight lifting. No 
significant difference in the number of bench presses 
occurred in the males.
4. No significant difference was determined for 
trunk flexion flexibility, and, consequently, no 
difference in the flexibility levels are assumed to 
exist between Type II diabetics and the normal 
population.
Recommendat ions
Based on the results and observations of this 
research, the following recommendations are made:
1. New norm tables should be developed for male 
and female Type II diabetics, ages 40 and above, as 
significant differences were determined between 
diabetics and the apparently healthy population in 
many of the fitness variables.
2. The same testing should be performed in large 
groups of younger male and female Type II diabetics to 
determine whether the same fitness differences noted 
in this study would prevail. If differences occur,
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new fitness norms should also be prepared for these 
age groups.
3. Since Murphy et al. (1981) found that the 
normal linear relationship between V02 and HR was not 
maintained in exercising diabetic rats without 
insulin, and considering the fact that this study used 
submaximal heart rates to predict V02 max, further 
investigation in this areas is recommended in order to 
assure the validity of this prediction in Type II 
diabetics.
4. Since male and female diabetics both failed to 
show a significant increase in percent body fat in 
conjunction with the significantly higher body weight, 
a correlational study between hydrostatic weighing and 
skinfold measurements is recommended for Type II 
diabetics. The validity of the skinfold measurements, 
as performed in this study, may be questioned as the 
diabetic population is generally known to have a 
higher plasma lipid concentration as well as increased 
fat content of certain organs (namely the liver). The 
increase in deep fat would probably not be reflected 
in the currently used skinfold equations.
APPENDIX A 
Letter of Explanation
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April 29, 1988
Dear potential participant:
The department of exercise physiology at the 
University of Nevada, Las Vegas, is currently working 
with the Inter-national Diabetic Center in 
Minneapolis, Minnesota on a study designed to assess 
the exercise tolerance of type II diabetics. This is 
the first step necessary before exercise programs can 
be designed specifically for the diabetic population.
We are in need of approximately 100 type II diabetics 
between the ages of 20 and 65 who would be willing to 
donate no more than one hour of their time for this 
purpose. The procedure will be completed at the UNLV 
campus lab and will, in general, consist of a fitness 
test and a determination of percent body fat (please 
see the separate, enclosed sheet for a more detailed 
explanation of the actual testing procedure).
If you meet the above criteria and are interested in 
assisting us, please have your doctor read the 
enclosed explanation sheets and sign the medical 
release form. Then please make an appointment for 
testing by calling 739-0980 or if no answer, leave a 
message with Janice at 739-3766 and I will return your 
call.
Thank you for your time and consideration.
Very cordially,
Joan K. MacDonald 
Research Associate
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Type II Diabetic Exercise Tolerance Assessment 
General Explanation of the Testing Procedure
Once you have been selected and medically cleared by 
your physician to be a participant in this study, you 
will be asked to come to the Exercise Physiology Lab
on the UNLV campus to complete the following battery
of tests at no cost to you (this is the Y's Way to 
Fitness test battery):
1. Standing height
2. Weight
3 Resting heart rate
4. Resting blood pressure
5. Skinfold measurements (consists of pinching 
the skin in several sites for the 
determination of percent body fat)
6. 3-minute step test (consists of fairly slow 
stepping up and down on a special bench for 
three minutes in order to evaluate 
cardiovascular fitness)
7. Flexibility test (consists of sitting on the 
floor with the legs fully extended and simply 
bending over at the hips and reaching as far 
as possible)
8. Bench Press (consists of lifting a set of 
barbells off your chest as many times as 
possible while lying on a weight bench; 35 lb 
for women and 80 lb for men)
9. Situps (consists of properly performing as 
many situps as possible in one-minute)
10. Submaximal bicycle test (consists of riding a 
stationary bicycle for approximately 10 
minutes while your heart rate response is 
monitored)
Your confidentiality as a participant will be 
maintained by keeping all files in a locked cabinet to 
which only research personnel will have access. All 
statistial data in the computer files will be coded. 
Names, addresses and telephone numbers will not be 
released without your written permission, and all 
subject data will be destroyed after final 
summarization.
Additional information, such as a medical history and 
signed informed consent form will be obtained at a 
later date. We will also notifiy you as to the type 
of clothing to wear for the test, when and what to eat 
or drink, etc. prior to your actual testing on campus.
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MEDICAL CLEARANCE FOR TYPE II DIABETIC STUDY
at UNLV
I, Dr. _____________________________________  am aware
(physician's name)
that my patient, _______________________________  is
(patient's name)
interested in participating in a study designed to 
test the fitness level of Type II diabetics at UNLV's 
Department of Exercise Physiology. I understand that 
the Y's Way to Fitness battery of tests will be the 
standard testing tool, and that each patient will only 
undergo testing only one time. It is currently my 
professional decision to (please initial the 
appropriate space):
1. ______ grant medical clearance for my patient
to participate.
2. ______ deny medical clearance at the present
time.
(Printed physician's name)
(physician's signature)
(date)
APPENDIX B 
Informed Consent
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Consent to Participate in a 
Research Study 
International Diabetes 
Center/University of Nevada, 
Las Vegas 
and YMCA of the USA
Title of Study: The physical fitness level of Type II diabetics.
Purpose: You are being asked to participate in a research study. 
We hope to learn if there is a difference in the physical 
fitness levels of Type II Diabetics and a similar apparently 
healthy population.. This is the first step in determining 
exercise programs for diabetics.
Subjects: Because you are an adult (between the ages of 20-65 
years) and a Type II Diabetic you have been recruited as a
Procedures: If you decide to volunteer, you will be asked to get 
medical clearance from your personal physician. If medically 
cleared you will have the following tests administered to 
you:
This test battery is the "Y's Way to Physical Fitness" 
fitness evaluation tool and has been administered to 
thousands of adults and excellent norms have been developed. 
The test requires approximately 30 minutes to take.
Risks: Anytime adults exercise there is a potential risk. The 
medical clearance and physical fitness evaluation attempts 
to define limitations or contraindications for exercise. 
While testing there is always risk of tripping or falling. 
Muscle soreness and stiffness usually occurs in beginner 
exercisers. Overexertion can result in nausea and/or 
fainting. Every effort will be made to monitor exercise in­
tensity and to provide safe supervison, and to safeguard 
your health, although you agree to look to your personal 
physician for medical care and treatment. The test battery 
is a sub maximal one.
Benefits: There are obvious benefits to this research. No physi­
cal fitness norms have been established for the diabetic 
population. Norms will enable diabetics to compare their 
fitness level with others, it will also give a starting 
point for an exercise program and will enable participants 
to measure improvement in fitness due to exercise.
subject.
Height
Weight
Resting heart rate 
Resting blood pressure 
Skinfold caliper measurements
3 minute step test 
Flexibility test 
Bench press (Men 80 lbs- 
women 35 lbs.)
One minute timed situps 
Submaximal bicycle test(7 sites)
Confidentiality: Subject's confidentiality will be maintained by 
keeping subjects files in a locked file. Only research per­
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sonnel have access to the files. Statistical data in com­
puter files are coded. Names, addresses and telephone num­
bers will not be released without subjects permission. At 
the conclusion of the study or when subjects leave the 
study, their files will be destroyed after data is 
summarized.
Right to refuse or withdraw: You may refuse to participate in any 
part of this study and you may change your mind about being 
in the study and withdraw after the study has started.
Questions; Any questions you had about the study, its purpose, 
design, methodology, procedures, or significance have been 
answered to your satisfaction. If you have additional ques­
tions later research personnel will be happy to answer them.
Your signature below will indicate that you have decided to 
volunteer as a research subject and that you have read the 
information provided above and understand the study.
Date:_____________  ______________
signature of participnat
Date: ____________  ___________ _____
signature of witness
Print Participant name; 
Print Witness name:
APPENDIX C 
Medical History 
and
Physical Activity Questionnaire
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The Y's Hay to Diabetes Control 
International Diabetes Center/University of Nevada, Las Vegas
and the YMCA of the USA
Questionnaire (card 1)
Name Date / / Time
Address
Home Phone Work Phone
Name, address and phone number of physician who manages your 
diabetes care:
Note: All spaces must be filled in, if necessary with 0, unless 
no data, then leave blank.
______________ (1-4) Identification number
  (5) Sex (l=male, 2=female)
______  (6,7) Age (years on day of test)
______  (8,9) Height in inches.
__________ (10-12) Height in pounds.
Health History (l=yes; 2=no; 3=don't know)
__  (13) Heart disease
__  (14) High blood pressure
__  (15) Diabetes
(16) Lung disease
__  (17) Kidney problems
__  (18) Muscle disease
__  (19) Back/joint problems
__  (20) Arthritis
__  (21) Eye Problems
__  (22) Stroke, Blood vessel or
circulatory problems
__  (23) Are you currently 
medication (l=yes; 2-no)
taking
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If yes, give name of medication, reason for taking it, and number 
of times taken daily.
(24,25) Year of onset of Diabetes 
(26,27) Age at onset of Diabetes
Nutrition
(28) Are you overweight (l=yes; 
2=no)
(29) If yes, approximately how many 
pounds (l=under 10 lbs; 2=10- 
20 lbs; 3=over 20 lbs.)
(30) Are you now on a weight con­
trol program? (l=yes; 2=no)
(31-34) If yes, how many calories?
(35,36) Percent cholesterol (if known)
(37,38) Percent fat (if known)
(39,40) Percent protein (if known)
Exercise
(41) Do you now engage in sports or
fitness activities on a 
regular basis (l=yes; 2=no)
(42) If yes, what sport or activity
l=Swimming 7=Basketball
2=Running 8=Cycling
3=Exercise class 9=Other___
4=Racguet Sports __________.
5=Walking 
6=Weight Training
(43) If yes, how often (days per
week)
(44-46) If yes, how long per session
(mins)
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(47)
(48)
(49)
How physically fit do you feel 
now?
l»Unfit 4-Above average
2-below avg. 5-Very fit.
3*about avg.
Have you ever been told that 
you should not exercise 
vigorously? (l=*yes; 2=no)
When exercising vigorously, do 
you usually eat more, change 
insulin?
l=decrease insulin 
2=take extra feeding 
3«both 1 & 2 
4=neither 1 or 2
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The Y's Way to Diabetes Control 
International Center/University of Nevada, Las Vagas 
and the YMCA of the USA
Test Results
Name
Tester (initials) 
Date J  / Time
Note: All spaces must be filled in, if necessary with 0, unless 
no data, then leave blank, (e.g. if individual tries and cannot 
do one bench press fill in 0-if the person has a sore arm and 
cannot do a bench press-leave blank).
Card 2
(1-4)
(5)
(6,7)
(8-10)
(11-13
(14-16
(17,18
(19-21
(22,23
(24,25
(26,27
(28,29
(30,31
(32,33
(34,35
(36,37
(38,39
(40-42
(43,44
Identification Number
Sex (l=male, 2=»female)
Age (years on day of test)
Sitting systolic pressure
Sitting diastolic pressure
Sitting heart rate
Height (nearest inch)
Weight (nearest pound)
Pectoral Skinfold
Abdominal Skinfold
Ilium Skinfold
Axilla Skinfold
Tricep Skinfold
Scapula Skinfold
Front Thigh Skinfold
Percent fat (sura of 6 men, sum 
of 5 women)
Percent fat (sum of 4 men, sum 
of 3 women)
3 minute step test (recovery 
HR-1 min)
Flexibility (nearest inch)
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  --  (45,46)
  --  (47,48)
------  (49-51)
------  (52-54)
  --  (55-58)
------  (59-61)
  --  (62-65)
-k-i-    (66-68)
-(-JL __  (69-72)
  (73)
Bench press (repetitions, 35 
lbs women, 80 lbs men, 60 bpm, 
start down position)
Timed Situps
1st workload used to graph 
HR at above
2nd workload used to graph
HR at above
Predicted PWC MAX
Predicted MAX V02-Liters 
(leave 2nd space alone with 
decimal point)
V02 Max (ml/kg/min) divided 
last number by weight (kg) - 
(leave 3rd space alone with 
decimal point)
Location of testing. (1= 
Ridgedale, 2=UNLV, 3=San
Diego)
4*»_________ , 5=_________
6“___________ , 7=___________
8=_________ , 9=_________
Glucose 1 
Glucose 2
APPENDIX D 
YMCA Guide to Setting Workloads 
and
Physical Working Capacity Sheets
DIRECTIONS 1
3
1st Workload
2nd Workload
3rd Workload
4th Workload
Set the first work load at 150 KGM/min (0.5 KP)
If HR in third min is:
Less than « )  80, set 2nd load at 750 KGM (2.5 KP)
80 to 89, set 2nd load at 600  KGM (2.0KP)
90 to 100, set 2nd load at 450  KGM (1.5 KP)
G reater than ( > )  100, set 2nd load at 300  KGM (1.0KP)
Set third and fourth (if required) loads according to the loads in colum 
below second loads
FIGURE I
H F n
80-89 9<m 63-  hr>100H R < 80
600 KGM 
2.0 KP
750 KGM 
2.5 KP
450 KGM 
1.5 KP
600 KGM 
2.0 KP
450 KGM 
1.5 KP
900 KGM 
3.0 KP
750 KGM 
2.5 KP
1050 KGM 
3.5 KP
900 KGM 
3.0 KP
300 KGM 
1.0 KP
750 KGM 
2.5 KP
600 KGM 
2.0 KP
150 KGM 
0.5 KP
(< ) Less than (> )  Greater than
MA
XI
MU
M 
PH
YS
IC
AL
 
WO
RK
IN
G 
CA
PA
CI
TY
 
PR
ED
IC
TI
ON
.
106
I ! § 8 8 5
S
so
•5
i
Xa
£35
o
<
Y  u a ui
Is
! l i
I
I I
T T
-I— I— i-
4-4-
j_ i-~rr
o_l
—J— L-
! I
i r |l
I I
l I
_I_L
! i
4-4
J_L
0_L
-i—+-
! I
8 8
g o o o
. «  <n o  «>
(M ft ft -
g « o n O
O) *  *2 a  m
g ft O O Os ’ s : :
8 “ ; ip r> <
VI '
S ft i 
n « «
g <P « 55 «
§*:
§2’ n o
P P
E ^  £ uj ui
Ui Ui
PHYSICAL WORKING CAPACITY TEST
NAME.
SEAT
Workload Heart Rate
2nd min
150 kgm ___________3rd min.
2nd min.
kgm ___________3rd min.
 2nd min.
kgm ___________3rd min.
___________2nd min.
kgm ___________3rd min.
HEIGHT
1st WORKLOAD
2nd WORKLOAD
3rd WORKLOAD
4th WORKLOAD
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APPENDIX E
Descriptive Data and Fitness Results on Las Vegas
Diabetics
Means and Standard Deviations on all Data 
from Combined Diabetic Population
Means and Standard Deviations on all 
YMCA Data
Percentile Rankings for Diabetics 
and Apparently Healthy
Raw Data on Diabetics
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DESCRIPTIVE DATA on LAS VEGAS DIABETICS
FEMALES
Sub j ect' s Wt
Initials Age (lbs) RBPS RBPD RHR % Fat
JB 65 142 118 88 96 31.2
OD 58 221 142 90 66 **
MEF 47 144 90 62 66 29.6
LH 62 151 122 70 76 37.7
TH 58 125 118 70 88 25.0
CK 63 183 140 90 84 40.4
ML 56 179 140 82 78 40.6
U 63 128 118 70 84 32.7
VR 62 207 150 90 72 31.7
NU 59 169 130 80 72 31.2
MN 67 162 138 78 80 35.0
SS 54 186 122 84 72 37.1
BL 54 243 140 82 108 **
BW 55 176 110 70 68 **
MEAN 58.8 172.6 127.0 79 79.3 33.8
SD 5.3 34.4 16.0 9.2 12.0 4.8
Subject's
Initials Age
MALES
WT
(lbs) RBPS RBPD RHR % Fat
AA 57 194 170 106 74 26.6
JD 61 154 132 64 72 18.7
WD 61 153 158 86 58 19.7
FD 63 183 120 76 68 23.6
SD 69 159 120 80 70 27.5
CG 63 174 150 92 80 25.3
GH 62 177 130 82 68 25.1
SS 62 185 150 84 70 25.1
JM 60 204 140 70 60 28.8
NT 53 243 138 94 84 26.3
WT 58 182 138 84 68 20.1
EG 61 182 122 72 88 27.6
MEAN 60. 8 182.5 139 82. 5 71. 7 24.6
SD 3.9 24.5 15.7 11. 5 8.9 3.5
* Resting blood pressures— systolic and diastolic
** could not be obtained
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FITNESS RESULTS on LAS VEGAS DIABETICS
FEMALES
Subj ect's 
Initials
PWC
Max
V02
Max
Flexi­
bility
Bench
Press
Sit­
ups
Step
Test
JB 320 15.5 19.5 9 13 160
OD * * * *** 13.0 24 0 *
MEF 628 23.8 12.0 0 10 108
LH 600 21.9 16.0 7 0 124
TH 704 30.1 13.0 1 0 *
CK 738 21.4 10.0 15 0 *
ML 495 15.9 13.5 17 4 *
LT 394 18.8 10.0 1 0 *
VR 548 14.9 14.0 5 0 *
NU 854 26.2 10.0 16 4 *
MN 1060 32.6 5.0 1 0 *
SS 500 14.2 0.0 2 6 145
BL * * 12.0 10 0 *
BW 1000 28.7 13.5 10 13 124
MEAN 653.4 22.0 11.5 8.4 3.4 132.2
SD 229.0 6.4 4.5 7.1 4.8 18.2
MALES
AA 818 41.8 8.0 10 10 *
JD 713 47.3 6.0 1 0 118
WD 744 25.8 11.0 6 12 90
FD ** ** 2.0 1 0 **
SD 469 17.2 15.0 1 12 135
CG 588 18.7 6.0 5 15 121
GH 1400 38.6 13.0 6 16 109
SS 979 26.9 9.0 1 0 134
JM •kith *** 15.0 27 9 106
NT 970 20.3 15.0 14 5 143
WT 711 20.9 18.0 0 17 102
EG 800 22.9 11.0 2 0 135
MEAN 819.2 28.0 10.8 6.2 8.0 119.3
SD 256.2 10.7 4.5 7.5 6.4 17.4
*— could not complete due to fatique
**— not completed as subject was taking a beta blocker 
***— advised against completing due to numerous PVCs
MEANS and STANDARD DEVIATIONS ON ALL DIABETICS
FEMALES 
N Mean SD
Age 88 55 8.1
Wt 87 174 36.3
Resting HR 88 78 13.5
Resting BP 
Systolic 87 135 12.8
Resting BP 
Diastolic 85 84 7.9
% Fat 80 33 6.7
PWC max 84 767 203.1
V02 max 83 26 6.5
Flexibility 87 15 4.3
Bench press 84 15 8.7
Situps 86 10 10.0
Step test one- 
minute recovery HR 73 123 18.7
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MEANS and STANDARD DEVIATIONS ON ALL DIABETICS
MALES
N Mean SD
Age 138 56 8.4
Wt 136 196 29.8
Resting HR 138 75 11.9
Resting BP 
Systolic 138 140 14.0
Resting BP 
Diastolic 126 85 8.9
% Fat 132 25 6.3
PWC max 121 1103 369.1
V02 max 122 32 11.4
Flexibility 136 12 3.9
Bench press 136 10 6.4
Situps 138 17 9.3
Step test one- 
minute recovery HR 123 119 18.0
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MEANS and STANDARD DEVIATIONS ON ALL YMCA DATA
FEMALES
N Mean SD
Age 2000 53 9.1
Wt 1934 147 25.9
Resting HR 1929 72 10.3
Resting BP 
Systolic 1917 121 14.8
Resting BP 
Diastolic 1936 77 9.6
% Fat 1740 31 6.9
PWC max 1021 767 264.1
V02 max 1012 30 9.3
Flexibility 1841 16 4.1
Bench press 1286 13 9.3
Situps 1491 16 9.5
Step Test one- 
minute recovery HR 627 117 18.8
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MEANS and STANDARD DEVIATIONS ON ALL YMCA DATA
MALES
N Mean SD
Age 2226 53 9.3
Wt 2098 186 27.7
Resting HR 2151 71 11.2
Resting BP 
Systolic 2177 129 14.7
Resting BP 
Diastolic 2178 81 9.4
% Fat 1932 24 5.6
PWC max 1220 1171 382.2
V02 max 1208 34 10.4
Flexibility 2101 12 5.2
Bench press 1534 13 8.8
Situps 1989 23 10.6
Step Test one- 
minute recovery HR 795 109 19.4
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PERCENTILES ON DIABETIC FEMALES
Weight, Resting BP and HR, and % Fat
Percentile Wt RBPS RBPD RHR % Fat
5 124 118 70 59 20
10 129 119 72 61 22
15 136 122 74 64 26
20 145 123 78 65 28
25 150 124 80 67 28
30 153 127 80 68 30
35 155 130 82 69 32
40 160 132 82 72 32
45 166 134 84 75 32
50 171 138 84 77 33
55 175 138 86 79 34
60 177 139 88 81 35
65 179 139 90 84 36
70 182 140 90 85 37
75 186 140 90 87 38
80 193 144 90 88 39
85 212 150 92 89 40
90 238 151 92 99 42
95 254 158 94 101 43
100 260 172 98 110 45
Skinfold Measurements
Per­
centile Chest
Ab­
domen Ilium
Ax­
illa
Scap­
ula Tricep Thigh
5 16 14 14 15 11 15 18
10 19 20 16 18 15 16 19
15 20 24 18 20 18 17 23
20 23 26 20 22 19 19 25
25 25 29 22 23 21 20 27
30 27 32 23 24 22 20 29
35 27 33 24 27 25 21 30
40 28 34 26 30 25 23 31
45 29 37 27 31 26 24 31
50 29 38 28 32 27 25 33
55 32 40 31 34 29 27 34
60 36 42 32 35 29 27 35
65 37 44 36 36 30 28 35
70 39 48 39 38 31 29 37
75 41 49 42 39 33 31 38
80 44 50 43 40 34 35 39
85 47 53 44 44 35 36 47
90 48 56 50 50 37 39 50
95 59 58 52 52 46 43 51
100 66 66 60 56 56 50 56
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PERCENTILES ON DIABETIC FEMALES (continued)
PWC max, V02 max, Flexibility, Bench Press, 
Sit-ups, and Step Test
Per­
centile
PWC
max
V02
max
Flexi­
bility
Bench
Press
Sit-
ups
Step
Test
5 457 15 7 0 -0 91
10 512 17 7 4 -0 98
15 557 19 9 6 -0 103
20 602 21 11 8 0 106
25 632 21 11 8 0 112
30 654 21 13 10 0 115
35 676 23 13 10 2 117
40 695 23 13 12 4 120
45 713 24 13 14 6 121
50 735 25 13 14 6 123
55 757 25 15 14 10 126
60 781 27 15 16 12 128
65 813 27 15 18 12 130
70 851 27 17 20 14 134
75 895 29 17 20 18 136
80 932 31 17 20 20 140
85 985 33 19 24 22 144
90 1032 33 19 24 22 148
95 1167 35 21 32 28 152
100 1317 46 24 34 36 160
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PERCENTILES ON YMCA FEMALES 
Weight, Resting BP and HR, and % Fat
Per­
centile Wt RBPS RBPD RHR % Fat
5 112 98 61 56 18
10 118 101 65 59 21
15 122 106 68 61 22
20 126 110 69 63 24
25 128 111 70 64 25
30 131 113 70 65 26
35 134 116 73 68 27
40 136 117 74 69 28
45 139 118 76 71 29
50 142 119 77 72 30
55 145 122 80 73 31
60 149 124 80 73 32
65 152 126 81 76 33
70 155 129 82 77 34
75 161 131 82 79 35
80 167 134 85 80 36
85 173 137 88 83 38
90 183 141 89 85 39
95 200 146 92 89 41
100 236 168 110 106 50
Per­
centile Chest
Skinfold Measurements
Ab- Aux- Scap- 
domen Ilium ilia ula Tricep Thigh
5 4 11 6 6 7 10 14
10 5 15 9 9 10 13 18
15 7 18 11 10 11 15 21
20 8 20 13 12 11 17 23
25 9 22 14 13 12 18 25
30 11 24 17 14 14 19 27
35 12 26 18 16 15 19 29
40 13 27 19 17 16 21 30
45 15 28 21 18 18 22 31
50 16 31 22 20 18 22 33
55 17 32 23 21 19 23 34
60 19 34 25 21 20 25 35
65 20 35 26 22 22 26 37
70 21 36 27 24 23 27 39
75 24 39 30 26 24 29 41
80 25 40 31 28 26 30 43
85 28 43 34 30 28 31 46
90 29 47 38 32 32 34 50
95 33 51 42 36 25 38 54
100 46 68 56 46 48 48 68
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PERCENTILES ON YMCA FEMALES (continued)
PWC max, V02 max, Flexibility, Bench Press, 
Sit-ups, and Step Test
Per­
centile
PWC
max
V02
max
Flexi­
bility
Bench
Press
Sit-
ups
Step
Test
5 399 16 7 0 0 86
10 467 19 9 l 2 92
15 505 20 11 2 5 96
20 543 22 11 4 8 100
25 577 23 13 5 9 103
30 611 24 13 6 10 106
35 642 25 13 8 12 109
40 671 27 15 9 13 111
45 701 27 15 10 14 114
50 729 28 15 12 16 117
55 757 30 17 12 17 119
60 790 31 17 13 18 121
65 824 32 17 14 20 124
70 864 33 17 17 21 126
75 913 35 19 18 22 129
80 963 36 19 21 24 132
85 1022 39 19 22 26 136
90 1125 42 21 25 29 141
95 1275 47 21 30 32 148
100 1784 69 28 46 46 178
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PERCENTILES ON DIABETIC MALES
Weight, Resting BP and HR, and % Fat
Percentile Wt RBPS RBPD RHR % Fat
5 153 119 70 55 14
10 157 123 71 58 16
15 162 126 75 61 17
20 170 128 78 65 19
25 174 130 79 67 20
30 178 131 80 69 20
35 181 132 82 70 21
40 185 138 83 71 22
45 189 139 86 73 23
50 193 140 86 74 24
55 195 140 87 77 25
60 198 143 88 77 26
65 201 144 90 78 26
70 206 148 91 79 27
75 213 150 91 81 28
80 221 152 92 83 29
85 231 154 95 87 30
90 241 158 96 90 32
95 257 160 99 94 36
100 272 180 108 112 43
Per­
centile Chest
Skinfold Measurements
Ab- Ax- Scap- 
domen Ilium ilia ula Tricep Thigh
5 8 11 11 8 11 5 7
10 12 17 13 12 11 5 9
15 12 18 14 14 15 5 9
20 14 21 15 14 17 7 11
25 16 23 18 14 17 7 11
30 18 25 19 16 17 9 11
35 18 26 21 18 19 9 13
40 20 27 22 18 19 9 13
45 20 29 25 18 21 9 13
50 20 30 26 20 21 11 15
55 22 31 27 22 23 11 15
60 22 33 28 24 23 13 15
65 24 34 31 24 25 15 17
70 24 37 33 24 27 15 19
75 26 39 35 26 29 15 19
80 28 46 37 28 31 17 19
85 30 49 39 30 33 17 21
90 34 53 43 32 35 19 27
95 36 58 49 36 37 21 29
100 40 68 56 44 46 32 38
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PERCENTILES ON DIABETIC MALES (continued)
PWC max, V02 max, Flexibility, Bench Press, 
Situps, and Step Test
Per­
centile
PWC
max
V02
max
Flexi­
bility
Bench
Press
Sit-
ups
Step
Test
5 575 17 4 -0 0 83
10 720 21 6 0 2 95
15 750 21 8 2 4 99
20 780 22 8 4 8 103
25 810 23 8 4 10 105
30 867 25 8 6 12 109
35 928 26 10 6 14 114
40 988 27 10 8 16 119
45 1041 29 10 10 18 120
50 1087 30 12 10 18 121
55 1131 33 12 10 20 122
60 1168 34 12 10 20 123
65 1206 35 14 10 22 125
70 1257 37 14 12 22 127
75 1312 38 14 12 24 129
80 1363 41 14 14 24 133
85 1413 43 16 14 26 137
90 1553 47 16 16 30 139
95 1688 51 18 20 32 144
100 2414 67 20 30 34 172
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PERCENTILES 
Weight, Resting 
Percentile Wt
ON YMCA MALES 
BP and HR, and % 
RBPS RBPD
Fat
RHR % Fat
5 144 107 64 53 14
10 151 109 70 57 17
15 157 113 71 60 18
20 161 116 72 61 19
25 165 119 75 62 20
30 168 120 78 64 21
35 171 121 78 65 22
40 176 123 79 66 22
45 179 125 80 68 23
50 182 126 80 69 24
55 186 127 82 72 24
60 189 129 83 73 25
65 192 132 84 74 26
70 197 135 86 76 27
75 201 138 88 77 28
80 206 139 90 80 29
85 206 141 91 82 30
90 220 146 92 85 31
95 232 156 98 92 33
100 312 214 132 118 38
Per­
centile Chest
Skinfold Measurements
Ah- Ax- Scap- 
domen Ilium ilia ula Tricep Thigh
5 7 14 8 9 10 5 7
10 8 16 11 12 10 7 9
15 10 19 14 12 11 7 10
20 12 22 15 13 12 9 11
25 14 23 16 14 14 9 11
30 14 24 18 16 15 9 13
35 15 26 19 17 15 9 13
40 16 27 20 18 16 11 14
45 18 28 22 20 18 11 15
50 19 30 23 20 19 11 15
55 20 31 24 21 19 13 17
60 20 32 26 22 20 13 18
65 22 34 27 24 22 13 18
70 23 36 28 25 23 15 19
75 24 38 31 25 24 15 21
80 27 40 32 26 26 17 22
85 28 43 35 29 28 19 23
90 32 46 38 32 31 19 27
95 36 51 43 36 35 23 31
100 48 64 56 46 44 32 44
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PERCENTILES ON YMCA MALES (continuted)
PWC max, V02 max, Flexibility, Bench Press, 
Sit-ups, and Step Test
Per­
centile
PWC
max
V02
max
Flexi­
bility
Bench
Press
Sit-
ups
Step
test
5 632 18 2 0 5 76
10 749 21 4 2 9 83
15 805 24 6 4 12 88
20 862 25 8 5 13 92
25 914 26 10 6 14 95
30 956 27 10 8 17 98
35 999 29 10 8 18 100
40 1041 30 10 9 20 102
45 1085 31 12 10 21 106
50 1127 33 12 12 22 110
55 1170 34 12 13 24 112
60 1212 36 14 14 25 114
65 1266 37 14 16 26 117
70 1320 38 14 17 28 119
75 1375 39 16 20 29 122
80 1454 42 16 21 30 125
85 1535 44 16 22 33 129
90 1655 47 18 25 37 132
95 1864 52 20 29 41 141
100 2792 76 40 42 54 162
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RAW DATA ON LAS VEGAS DIABETIC FEMALES— SKINFOLD 
MEASUREMENTS, WORKLOADS AND HEART RATES
Skinfolds
ID Chest Abdomen Ilium Axilla Scapula Tricep Thigh
JB 29 34 26 25 31 22 30
OD 27 42 * 34 44 34 40
MEF 18 37 20 14 14 16 34
LH 41 42 38 34 28 29 39
TH 20 21 17 20 18 19 27
CK 19 50 42 24 44 35 37
ML 37 43 32 47 47 43 49
LJ 24 31 25 24 27 26 38
VR 33 22 24 25 27 32 37
NU 29 37 21 22 24 21 34
MN 28 41 30 * 40 30 31
SS 36 46 35 31 37 33 32
BL 17 34 28 27 29 29 *
*— could not be obtained
ID
Workloads and
1st wkld over HR at 1st 
110 HR (kgm) wkld
heart rates
2nd wkld over 
110 HR (kgm)
HR at 2nd 
wkld
JB 150 142 300 164
OD ** ** ** **
MEF 300 114 450 140
LH 150 110 300 126
TH 150 114 300 126
CK 150 110 300 122
ML 150 118 300 138
LJ 150 113 300 140
VR 300 125 450 145
NU 300 113 450 126
MN 150 112 300 120
SS 150 126 300 138
BL ** ** ** **
BW 300 120 450 130
**— could not complete the bicycle test
RAW DATA ON LAS VEGAS DIABETIC MALES— SKINFOLD 
MEASUREMENTS, WORKLOADS AND HEART RATES
Skinfolds
ID Chest Abdomen Ilium Axilla Scapula Tricep Thigh
AA 26 35 26 29 29 18 16
JD 8 19 24 24 28 26 9
WD 18 14 18 18 28 19 9
FD 19 27 20 22 22 16 13
SD 20 26 23 19 20 21 20
CG 21 29 26 18 15 10 19
GH 37 22 39 27 23 14 9
SS 25 33 23 22 23 12 16
JM 36 41 40 28 30 9 14
NT 50 40 36 33 43 10 11
WT 15 18 25 19 23 12 9
EG 19 34 28 26 25 19 16
ID
Workloads and Heart rates
1st wkld over HR at 1st 2nd wkld 
110 HR (kgm) wkld 110 HR
over HR at 2nd 
wkld
AA 450 114 600 134
JD 300 115 450 130
WD 450 109 600 135
FD * * * *
SD 300 115 450 147
CG 150 122 300 134
GH 300 114 450 120
SS 150 111 450 128
JM ** ** ** **
NT 150 126 450 141
WT 300 110 450 129
EG 300 118 450 132
*— on beta blocker (Inderol)
**— advised against continuing as subject began having 
numerous PVCs
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DIABETIC SUBJECT RAW DATA
Column 1: identifier code
Column 2: age
Column 3: weight (lbs)
Column 4: systolic blood p re s su re
Column 5: diastolic blood p re s su re
Column 6: re s t in g  h ea r t  ra te  (bpm)
Column 7: ches t  skinfold
Column 8: abdomen skinfold
Column 9: ilium skinfold
Column 10 axilla skinfold
Column 11 scapula skinfold
Column 12 tr icep  skinfold
Column 13 th igh  skinfold
Column 14 1st workload on submax bicycle te s t
Column 15 h ea r t  ra te  a t  1st workload
Column 16 2nd workload on submax bicycle te s t
Column 17 h ea r t  ra te  a t  2nd workload
Column 18 flexibility (in)
Column 19 bench p re s s
Column 20 1 minute timed s i tups
Column 21 step  te s t  (1 minute recovery  h ea r t  ra te )
89110 36 130 120 80 70 20 19 19 15
FEMALES 
20 13 20 300 110 450 135 24.0 15 25 104
89110 36 129 120 82 70 0 19 9 0 12 13 17 300 118 450 133 24.0 15 25 104
89110 39 170 150 0 90 30 45 40 40 35 42 45 150 120 300 135 13.0 9 10 135
89110 40 180 140 90 85 35 50 40 42 30 45 50 150 113 300 132 14.0 10 9 138
89110 41 155 150 90 90 40 44 38 30 35 30 45 300 121 450 140 18.0 15 2 115
89110 41 140 130 75 100 15 13 16 15 12 20 20 150 110 300 130 20.0 19 23 146
89110 41 154 150 92 87 0 44 28 0 26 28 44 300 121 450 135 18.0 15 0 115
89110 41 140 126 72 99 0 13 6 0 12 20 18 150 113 300 127 20.0 19 23 146
89110 42 257 160 95 100 65 65 55 50 35 35 40 150 120 300 145 8.0 35 1 153
89110 42 257 158 94 108 0 0 44 0 33 34 50 150 128 300 137 8.0 35 0 153
89110 42 257 158 94 108 0 0 44 0 33 34 50 150 128 300 137 8.0 35 0 153
89110 43 327 130 80 100 60 55 60 45 50 30 35 150 125 300 148 8.0 20 1 140
89110 43 130 120 75 80 15 15 20 20 15 15 30 150 110 300 125 18.0 20 28 115
89110 43 237 128 80 105 0 50 45 0 24 27 28 150 127 300 142 18.0 20 0 139
89110 43 128 118 74 78 0 12 18 0 9 15 31 150 112 300 123 18.0 20 28 114
89110 45 190 138 88 86 38 57 42 40 28 41 55 150 111 300 128 22.0 14 6 140
89110 45 160 135 95 100 40 40 45 40 35 20 25 150 120 300 149 20.0 10 15 135
89110 45 190 138 88 86 0 57 42 0 25 41 54 150 111 300 128 22.0 14 6 140
89110 45 160 132 92 100 0 39 30 0 26 19 19 150 125 300 144 22.0 10 15 133
89110 47 144 90 62 66 18 37 20 14 14 16 34 300 114 450 140 12.0 0 10 108
89110 49 155 102 72 64 30 41 24 29 24 25 28 300 110 450 126 13.0 99 15 100
89110 49 155 102 72 64 0 41 24 0 24 25 28 300 110 450 126 13.0 0 16 95
89110 50 185 150 90 90 50 50 36 35 30 30 35 300 112 450 135 12.0 20 1 130
89110 50 186 148 92 90 0 50 26 0 29 29 33 300 114 450 128 12.0 27 0 127
89110 51 176 138 78 62 30 38 33 32 22 22 18 450 118 600 135 15.0 25 13 0
89110 52 240 142 82 88 0 65 52 0 29 39 36 300 114 450 122 8.0 9 99 140
89110 52 227 122 86 63 38 65 53 40 35 20 50 300 115 450 128 13.0 99 5 110
89110 52 227 122 86 63 0 0 53 0 35 19 50 600 110 750 120 13.0 0 5 0
89110 53 170 125 85 70 25 26 23 25 23 15 27 450 110 600 125 16.0 30
126
30 102
89110 53 153 125 90 75 40 39 32 30 30 25 35 300 111 450 135 23.0 12 36 129
89110 53 170 122 82 65 0 26 23 0 23 15 27 450 110 600 125 16.0 30 30 102
89110 53 153 124 84 75 0 39 22 0 20 22 36 300 111 450 125 23.0 12 36 124
89110 54 150 140 90 85 30 35 20 35 25 20 35 150 111 300 130 17.0 20 20 125
89110 54 175 145 99 90 50 56 45 40 30 22 30 150 115 300 129 13.0 10 1 130
89110 54 173 144 99 88 0 56 43 0 29 12 23 150 115 300 129 13.0 10 0 128
89110 54 186 122 84 72 36 46 35 31 37 33 32 150 126 300 138 0.0 2 6 145
89110 54 243 140 82 108 17 34 29 27 29 29 0 0 0 0 0 12.0 10 0 0
89110 55 118 122 68 75 20 23 16 20 19 15 23 300 121 450 130 14.0 8 10 108
89110 55 145 135 80 90 35 37 24 30 25 25 38 150 113 300 128 19.0 21 18 124
89110 55 205 140 90 70 45 55 56 50 35 35 40 450 130 600 150 12.0 33 6 130
89110 55 118 122 68 75 0 23 16 0 19 15 23 300 121 450 130 14.0 8 10 108
89110 55 205 140 88 67 0 53 26 0 32 35 56 450 128 600 145 12.0 33 6 0
89110 55 145 132 80 92 0 37 24 0 15 25 38 150 113 300 128 19.0 21 18 124
89110 55 176 110 70 68 22 30 26 24 32 22 0 300 120 450 130 13.5 10 13 124
89110 56 180 150 90 85 50 50 50 45 50 25 35 300 110 450 130 13.0 12 1 119
89110 56 181 150 88 84 0 50 47 0 23 22 29 300 115 450 128 13.0 12 0 114
89110 56 179 140 82 78 37 43 32 47 47 43 49 150 118 300 138 13.5 17 4 0
89110 57 175 140 90 75 45 55 55 50 50 20 35 300 110 450 130 6.0 10 3 121
89110 58 160 135 85 77 50 45 40 50 55 35 45 300 111 450 127 10.0 11 8 130
89110 58 186 140 90 80 0 52 45 0 27 25 54 150 120 300 131 16.0 4 2 115
89110 58 221 142 90 66 27 42 0 34 44 34 40 0 0 0 0 13.0 24 0 0
89110 58 125 118 70 88 20 21 17 20 18 19 27 150 114 300 126 13.0 1 0 0
89110 59 175 130 80 60 45 48 31 40 28 23 35 300 110 450 130 16.0 20 21 134
89110 59 150 140 85 85 40 42 38 35 35 20 35 300 120 450 150 10.0 24 19 137
89110 59 250 120 90 55 60 65 0 55 60 50 40 450 115 600 135 13.0 20 1 140
89110 59 256 120 88 51 0 0 0 0 36 49 32 450 116 600 125 15.0 50 0 0
89110 59 173 130 78 59 0 48 31 0 18 23 32 300 113 450 129 16.0 20 21 134
89110 59 145 138 84 86 0 42 18 0 18 19 9 300 125 450 146 10.0 24 19 137
89110 59 256 120 88 51 0 0 0 0 36 49 32 450 116 600 125 15.0 50 0 0
89110 59 169 130 80 72 29 37 21 22 24 21 34 300 113 450 126 10.0 16 4 0
89110 60 150 140 90 75 28 29 30 26 25 30 30 300 120 450 140 12.0 13 11 145
89110 60 185 140 90 80 50 52 45 50 35 25 30 150 120 300 141 16.0 4 2 115
89110 60 176 138 78 62 0 38 33 0 22 22 18 450 118 600 135 15.0 25 0 72
89110 61 137 160 92 98 0 28 19 0 14 21 23 150 115 300 129 16.0 19 13 152
89110 62 151 135 80 73 25 30 29 25 26 29 37 300 120 450 143 13.0 20 12 150
89110 62 125 140 90 69 25 32 20 20 19 18 28 300 122 450 140 15.0 5 99 97
89110 62 180 150 85 70 30 25 25 30 30 25 35 450 110 600 135 17.0 9 19 104
89110 62 125 140 92 69 0 32 20 0 19 18 28 300 122 450 140 15.0 5 0 97
89110 62 151 136 78 73 0 30 29 0 26 29 37 300 120 450 143 13.0 20 12 150
89110 62 179 148 84 66 0 25 25 0 24 25 23 450 110 600 120 17.0 9 19 104
89110 62 151 122 70 76 41 42 38 34 28 29 39 150 110 300 126 16.0 7 0 124
89110 62 207 150 90 72 33 22 24 25 27 32 37 300 125 450 145 14.0 5 0 0
89110 63 190 130 85 70 46 56 44 35 30 29 30 450 110 600 135 6.0 15 1 94
89110 63 188 128 84 69 0 56 44 0 30 29 32 450 119 600 127 6.0 15 0 94
89110 63 183 140 90 84 19 50 42 24 44 35 37 150 110 300 122 10.0 15 0 0
89110 63 128 118 70 84 24 31 25 24 27 26 38 150 113 300 140 10.0 1 0 0
89110 64 180 140 0 82 30 32 17 35 28 37 50 300 118 450 129 19.0 24 21 122
89110 64 160 130 85 60 30 34 35 30 35 30 25 300 110 450 130 17.0 15 15 130
89110 64 130 130 75 70 15 12 17 15 20 7 20 450 115 600 145 18.0 17 22 120
89110 64 185 140 90 70 27 27 30 35 35 17 25 450 110 600 136 11.0 6 4 115
89110 64 180 140 99 82 0 32 17 0 28 37 50 300 118 450 129 19.0 24 21 122
89110 64 240 142 82 88 0 0 52 0 29 39 36 300 114 450 122 8.0 9 0 89
89110 64 155 128 82 58 0 34 24 0 21 29 35 0 0 0 0 17.0 15 15 0
89110 64 126 128 76 68 0 12 7 0 12 21 35 450 118 600 135 18.0 17 22 118
89110 65 175 150 0 85 30 35 28 30 25 35 45 300 120 450 130 13.0 20 22 125
89110 65 160 172 94 66 0 36 25 0 29 30 33 450 115 600 124 17.0 7 7 83
89110 65 142 118 88 96 29 34 26 25 31 22 30 150 142 300 164 19.5 9 13 160
89110 67 162 138 78 80 28 41 30 0 40 30 31 150 112 300 120 5.0 1 0 0
MALES 127
89110 35 170 120 70 65 13 23 13 8 11 5 7 600 113 750 133 1 6 .0 16 33 135
89110 35 168 120 70 62 13 23 13 39 11 5 7 600 113 750 133 1 6 .0 16 33 135
89110 36 200 126 78 79 15 25 24 15 24 15 22 300 143 450 155 1 6 .0 17 30 130
89110 36 200 126 78 79 15 25 24 15 24 15 22 300 143 450 154 2 6 .0 17 30 130
89110 40 173 110 72 71 8 18 17 10 10 12 13 600 120 750 125 1 5 .0 10 25 106
89110 40 250 150 90 90 25 55 30 25 35 15 15 300 121 600 128 1 3 .0 10 3 120
89110 40 185 120 85 77 23 20 20 15 11 15 12 600 115 750 125 1 4 .0 11 22 115
89110 40 173 110 72 71 8 18 17 10 12 10 13 600 118 750 124 1 5 .0 11 22 106
89110 42 180 120 80 75 10 20 20 15 11 15 12 600 118 750 124 1 4 .0 11 22 110
89110 45 248 148- 88 96 23 57 33 24 34 14 13 300 120 600 126 1 4 .0 9 0 119
89110 45 180 120 80 54 13 35 30 22 26 6 17 750 118 900 138 7 .0 10 25 96
89110 45 145 145 80 82 9 21 10 9 21 6 12 600 122 750 132 1 4 .0 9 20 125
89110 45 183 124 86 54 13 35 30 22 20 6 7 750 118 900 135 7 .0 10 25 96
89110 45 145 148 78 82 9 21 10 9 21 6 12 600 122 750 132 1 4 .0 9 20 0
89110 45 248 148 88 96 23 57 33 24 34 14 13 300 120 600 126 1 4 .0 9 0 119
89110 46 200 140 95 75 22 40 37 26 26 13 15 600 117 750 133 7 .0 15 20 120
89110 46 195 150 95 85 14 31 28 30 35 19 25 300 113 600 130 1 4 .0 31 23 125
89110 46 200 140 98 75 22 40 37 26 26 13 15 600 117 750 133 7 .0 15 20 120
89110 46 195 150 96 83 14 31 18 17 15 9 16 300 113 600 127 1 4 .0 31 23 125
89110 47 240 126 80 75 36 65 50 30 45 15 16 450 115 600 135 1 4 .0 30 21 100
89110 47 225 132 78 45 15 17 24 12 18 9 11 0 114 1200 134 1 1 .0 26 30 87
89110 47 198 145 72 80 21 38 35 25 22 18 19 600 125 750 140 9 .0 5 4 125
89110 47 245 150 90 71 35 55 40 30 30 15 25 750 110 900 135 1 0 .0 10 20 107
89110 47 160 130 75 60 19 33 35 30 35 19 20 600 112 750 128 8 .0 0 30 82
89110 47 240 126 78 74 36 0 50 31 35 12 16 450 115 600 130 1 4 .0 30 21 0
89110 47 225 132 78 46 15 17 24 12 18 9 11 0 114 1200 124 1 1 .0 26 30 87
89110 47 198 144 72 80 21 37 34 25 22 18 18 0 0 0 0 9 .0 0 4 0
89110 47 156 126 72 57 9 33 22 10 18 8 14 600 114 750 122 8 .0 0 34 82
89110 48 210 140 85 70 27 30 22 16 19 19 18 600 114 750 125 5 .0 15 16 113
89110 48 260 150 89 71 37 59 43 32 34 9 15 750 117 900 137 1 0 .0 10 20 106
89110 48 222 148 92 77 34 50 45 34 36 16 28 600 131 750 145 1 5 .0 19 16 143
89110 48 195 145 90 82 20 35 35 30 35 20 40 300 110 600 130 1 0 .0 15 15 120
89110 48 222 148 92 72 34 50 45 34 30 16 28 600 131 750 145 1 5 .0 19 16 143
89110 48 210 140 88 70 27 30 22 16 19 14 18 600 114 750 124 5 .0 15 16 113
89110 48 260 150 88 71 37 59 43 32 34 9 14 750 117 900 127 1 0 .0 10 20 106
89110 50 225 150 90 78 35 45 48 35 35 20 30 600 130 750 148 1 3 .0 13 15 140
89110 51 165 140 90 58 25 25 25 17 16 6 18 750 120 900 135 1 6 .0 10 25 100
89110 51 206 122 82 72 22 45 37 23 23 9 13 600 115 750 127 1 4 .0 15 31 124
89110 51 206 122 82 72 22 45 37 23 23 9 13 600 115 750 127 1 4 .0 15 31 124
89110 51 165 144 90 55 24 26 26 17 16 6 15 750 120 900 130 1 6 .0 10 25 100
89110 52 212 140 90 77 27 45 43 32 35 7 15 300 110 600 140 8 .0 5 30 129
89110 52 198 135 95 85 22 35 28 18 25 20 22 600 125 900 145 1 3 .0 10 18 128
89110 52 191 110 68 59 15 33 15 17 22 11 15 750 116 900 128 1 4 .0 15 31 103
89110 52 191 110 68 59 15 33 15 17 22 11 15 750 116 900 128 1 4 .0 15 31 103
89110 52 212 138 88 77 27 52 43 32 35 7 15 300 101 600 133 8 .0 5 30 129
89110 53 262 152 95 57 29 0 53 30 31 15 13 0 0 0 0 9 .0 0 0 0
89110 53 260 155 0 89 28 55 55 40 41 20 28 600 120 750 135 1 0 .0 10 20 130
89110 53 262 152 94 57 29 0 53 30 31 15 13 600 88 750 100 0 .0 20 20 0
89110 53 243 138 94 84 50 40 36 33 43 10 11 150 126 450 141 1 5 .0 14 5 143
89110 54 204 130 88 80 24 34 27 20 27 16 19 600 122 750 130 1 4 .0 13 32 138
89110 54 160 155 90 75 15 12 10 10 15 10 15 600 115 750 128 1 0 .0 9 29 99
89110 55 180 130 80 91 24 39 36 24 20 16 20 300 111 600 125 1 2 .0 5 23 141
89110 55 150 157 89 70 10 10 10 8 11 8 9 600 111 750 125 9 .0 4 32 91
89110 55 208 142 0 105 20 30 35 25 30 20 25 300 110 450 128 8 .0 2 18 120
89110 55 176 130 75 75 17 37 19 17 27 10 15 600 120 750 138 8 .0 13 24 131
89110 55 150 158 88 69 10 10 10 8 11 8 9 600 111 750 125 9 .0 4 32 91
89110 55 204 130 88 80 24 34 27 20 27 16 19 600 122 750 130 1 4 .0 13 32 138
89110 55 180 130 80 91 24 39 36 22 20 16 20 300 111 600 123 1 2 .0 5 23 141
89110 55 208 142 98 109 20 30 21 18 17 5 7 300 116 450 124 1 0 .0 0 15 0
89110 56 170 130 90 75 14 15 15 15 15 5 8 600 112 750 122 1 7 .0 12 25 120
89110 56 185 130 80 80 30 30 25 25 20 10 18 450 114 600 135 1 3 .0 1 10 120
89110 56 195 144 86 77 20 28 26 15 18 7 11 300 112 600 129 9 .0 10 18 122
89110 56 170 128 88 76 14 15 15 15 15 5 8 600 113 750 121 1 7 .0 12 25 119
89110 56 184 128 82 80 29 28 36 22 18 10 8 450 114 600 125 1 3 .0 0 10 118
89110 57 151 125 85 65 8 9 10 9 9 7 7 900 125 1050 141 1 2 .0 5 25 120
89110 57 200 130 90 100 12 15 16 14 25 9 10 300 133 600 154 5 .0 1 19 167
89110 57 300 180 0 80 40 65 65 60 55 35 45 150 112 300 140 1 3 .0 12 4 140
89110 57 195 150 90 75 30 35 40 25 35 20 25 450 112 600 140 8 .0 4 8 135
89110 57 151 126 80 64 8 9 10 9 9 7 7 900 127 1050 131 1 2 .0 5 28 79
89110 57 201 128 88 104 12 15 16 14 25 9 9 300 133 600 154 5 .0 0 19 167
89110 57 315 180 0 79 32 0 53 36 41 32 30 0 0 0 0 1 6 .0 12 0 0
89110 57 194 170 106 74 26 34 26 29 29 18 16 450 114 600 134 8 .0 10 10 0
128
89110 58 176 128 66 74 17 37 28 19 17 10 15 600 124 750 135 8 .0 13 24 131
89110 58 182 138 84 68 15 18 25 19 23 12 9 300 110 450 129 1 8 .0 0 17 102
89110 60 195 150 95 78 20 30 20 20 20 15 20 450 120 600 138 9 .0 5 9 108
89110 60 178 126 65 90 19 29 25 19 17 6 12 450 118 600 128 2 0 .0 10 15 123
89110 60 198 155 0 72 37 46 29 37 45 26 23 300 110 600 142 1 5 .0 9 10 123
89110 60 165 140 95 70 18 18 13 14 21 10 10 300 112 450 129 1 6 .0 13 26 112
89110 60 210 140 90 80 21 54 50 39 25 18 30 600 125 900 148 3 .0 20 22 140
89110 60 210 125 90 80 22 50 35 18 21 12 30 750 115 900 127 1 2 .0 10 20 111
89110 60 178 126 62 90 19 29 25 19 17 6 12 450 118 600 128 2 0 .0 10 15 123
89110 60 198 154 98 72 37 46 29 37 45 26 13 450 82 600 90 1 5 .0 9 10 77
89110 60 165 140 94 65 18 18 13 14 21 10 10 300 112 450 119 1 6 .0 13 26 112
89110 60 210 140 90 81 21 54 30 29 25 8 13 600 125 900 146 3 .0 20 22 140
89110 60 210 122 88 77 22 49 31 18 21 12 20 750 115 900 122 1 2 .0 10 20 111
89110 60 204 140 70 60 36 41 40 28 30 9 14 0 0 0 0 1 5 .0 27 9 106
89110 61 236 138 88 86 10 35 39 25 33 15 12 300 113 600 140 1 8 .0 10 15 154
89110 61 189 168 0 80 21 24 19 18 18 7 12 450 115 600 130 7 .0 4 7 101
89110 61 260 145 90 90 30 65 45 35 30 38 35 450 112 600 125 1 4 .0 17 1 120
89110 61 175 126 80 65 24 25 22 20 22 15 15 750 115 900 135 3 .0 7 23 130
89110 61 190 145 0 55 34 31 25 25 20 17 15 900 110 1050 135 1 6 .0 1 20 80
89110 61 236 138 88 86 10 35 39 25 33 15 12 300 113 600 140 1 8 .0 10 15 154
89110 61 265 144 88 91 29 0 42 32 29 36 33 450 113 600 122 1 4 .0 17 0 120
89110 61 173 126 80 66 24 25 22 19 22 5 13 750 115 900 125 3 .0 7 23 0
89110 61 187 144 98 56 34 31 26 26 19 17 11 900 115 1050 124 1 6 .0 0 21 78
89110 61 154 132 64 72 8 19 24 24 28 6 9 300 115 450 130 6 .0 1 0 118
89110 61 153 158 86 58 18 14 18 18 28 19 9 450 109 600 135 1 1 .0 6 12 90
89110 61 182 122 72 88 19 34 28 26 25 19 16 300 118 450 132 1 1 .0 2 0 135
89110 62 195 144 86 77 20 28 26 15 18 7 11 300 112 600 129 9 .0 10 18 122
89110 62 220 160 0 65 25 50 34 25 37 9 18 450 110 600 125 1 0 .0 10 0 123
89110 62 201 130 80 65 27 27 24 17 32 13 17 900 115 1050 128 9 .0 2 18 101
89110 62 220 158 99 63 25 50 34 25 37 9 18 0 0 0 0 1 0 .0 10 0 0
89110 62 201 130 78 61 27 27 24 17 32 13 17 900 115 1050 122 9 .0 2 18 101
89110 62 177 130 82 68 37 22 39 27 23 14 9 300 114 450 120 1 3 .0 6 16 109
89110 62 185 150 84 70 25 33 23 22 23 12 16 150 111 450 128 9 .0 1 0 134
89110 63 198 145 85 80 19 25 25 20 20 10 15 300 115 600 132 1 0 .0 11 14 125
89110 63 175 160 90 72 17 26 14 12 17 6 19 300 111 600 135 1 9 .0 10 17 133
89110 63 172 160 88 72 17 26 14 12 17 6 9 300 111 600 135 1 9 .0 10 17 133
89110 63 183 120 76 68 19 27 20 22 22 16 13 0 0 0 0 2 .0 1 0 0
89110 63 174 150 92 80 21 29 26 18 15 10 19 150 122 300 134 6 .0 5 15 121
89110 64 160 130 95 65 23 18 16 15 17 6 14 600 140 750 155 1 2 .0 8 20 141
89110 64 218 140 0 90 30 45 40 25 23 17 20 300 120 450 130 1 2 .0 17 13 141
89110 64 180 140 70 60 21 24 23 24 23 13 22 750 120 900 135 1 2 .0 11 24 119
89110 64 254 160 0 60 35 55 45 35 16 35 35 150 110 300 136 6 .0 10 3 140
89110 64 182 155 80 69 13 36 16 14 12 10 9 300 99 450 107 1 5 .0 8 13 88
89110 64 160 130 98 66 23 18 16 15 17 6 14 600 140 750 155 1 2 .0 8 20 141
89110 64 218 140 98 93 29 45 39 24 23 7 10 300 121 450 127 1 2 .0 17 13 141
89110 64 185 138 88 68 27 17 30 14 19 17 14 450 110 600 126 1 1 .0 6 4 110
89110 64 176 140 70 60 21 24 13 14 12 13 11 750 120 900 134 1 2 .0 11 24 119
89110 64 254 160 99 58 31 55 48 35 35 16 32 0 0 0 0 6 .0 0 4 0
89110 66 182 155 80 69 13 36 26 24 18 10 9 300 125 450 139 1 5 .0 8 13 120
89110 66 160 152 98 81 21 27 14 13 17 6 21 450 118 600 129 1 7 .0 10 23 120
89110 66 160 150 0 80 21 27 14 13 19 6 19 450 118 600 135 1 7 .0 5 15 125
89110 66 232 140 90 95 25 30 20 20 19 28 22 300 110 450 140 1 3 .0 15 20 118
89110 66 160 152 98 81 21 27 14 13 17 6 9 450 118 600 129 1 7 .0 10 23 0
89110 66 228 138 88 96 21 29 19 19 18 9 12 0 0 0 0 1 3 .0 15 20 116
89110 67 200 160 90 75 20 22 28 25 22 37 29 600 115 900 148 1 1 .0 20 24 120
89110 67 195 160 88 74 18 12 18 15 27 12 9 600 118 900 145 1 1 .0 21 24 119
89110 68 170 150 90 80 25 30 15 18 20 10 25 450 120 600 135 1 3 .0 11 20 120
89110 68 190 165 0 80 25 25 35 20 7 25 20 450 110 600 135 7 .0 4 7 111
89110 68 189 168 99 80 21 24 19 18 18 7 12 450 115 600 130 7 .0 4 7 101
89110 69 190 148 82 69 22 28 22 24 19 9 11 450 122 600 137 1 0 .0 7 10 125
89110 69 240 135 90 85 30 65 65 45 55 27 35 300 109 450 135 9 .0 6 5 125
89110 69 160 140 80 90 22 22 29 20 18 22 20 300 115 450 132 1 0 .0 6 10 120
89110 69 190 148 82 69 22 28 22 24 19 9 11 450 122 600 137 1 0 .0 7 10 98
89110 69 240 134 92 85 30 0 0 22 32 7 37 300 109 450 134 9 .0 6 0 0
89110 69 158 138 78 94 12 12 9 10 12 8 10 300 118 450 122 1 0 .0 0 10 0
89110 69 159 120 80 70 20 26 23 19 20 21 20 300 115 450 147 1 5 .0 1 12 135
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